CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | monomethoxybenzene |
|
Accession: | CHEBI:25235
|
browse the term
|
Definition: | Compounds containing a benzene skeleton substituted with one methoxy group. |
Synonyms: | related_synonym: | monomethoxybenzenes |
|
|
|
G |
Hnf1a |
HNF1 homeobox A |
decreases expression |
ISO |
isolariciresinol results in decreased expression of HNF1A mRNA |
CTD |
PMID:35755389 |
|
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
|
|
G |
Ldlr |
low density lipoprotein receptor |
decreases expression |
ISO |
isolariciresinol results in decreased expression of LDLR protein |
CTD |
PMID:35755389 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Pcsk9 |
proprotein convertase subtilisin/kexin type 9 |
decreases expression |
ISO |
isolariciresinol results in decreased expression of PCSK9 mRNA; isolariciresinol results in decreased expression of PCSK9 protein |
CTD |
PMID:35755389 |
|
NCBI chr 5:121,211,278...121,233,688
Ensembl chr 5:121,211,278...121,233,688
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
isolariciresinol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] |
CTD |
PMID:21191767 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression |
ISO |
isolariciresinol results in decreased expression of SREBF1 mRNA |
CTD |
PMID:35755389 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
decreases expression |
ISO |
isolariciresinol results in decreased expression of SREBF2 mRNA |
CTD |
PMID:35755389 |
|
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
|
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
multiple interactions decreases expression |
ISO |
[loliolide co-treated with pinoresinol] results in decreased expression of ACACA protein pinoresinol results in decreased expression of ACACA protein |
CTD |
PMID:31610126 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions decreases expression |
ISO |
[loliolide co-treated with pinoresinol] results in decreased expression of FASN protein pinoresinol results in decreased expression of FASN protein |
CTD |
PMID:31610126 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
multiple interactions |
ISO |
pinoresinol results in increased ubiquitination of and results in increased degradation of and results in decreased expression of NR1H2 protein |
CTD |
PMID:31610126 |
|
NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
multiple interactions |
ISO |
pinoresinol results in increased ubiquitination of and results in increased degradation of and results in decreased expression of NR1H3 protein |
CTD |
PMID:31610126 |
|
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
pinoresinol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] |
CTD |
PMID:21191767 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression multiple interactions |
ISO |
pinoresinol results in decreased expression of SREBF1 protein [loliolide co-treated with pinoresinol] results in decreased expression of SREBF1 protein |
CTD |
PMID:31610126 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Tnf |
tumor necrosis factor |
decreases secretion |
ISO |
pinoresinol results in decreased secretion of TNF protein |
CTD |
PMID:29740324 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:38521250 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of BAX protein |
CTD |
PMID:38521250 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased expression of BCL2 protein |
CTD |
PMID:38521250 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of CASP3 protein Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of CASP3 protein] |
CTD |
PMID:38521250 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases cleavage |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of CASP9 protein |
CTD |
PMID:38521250 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of CCNB1 protein |
CTD |
PMID:38521250 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cdc25c |
cell division cycle 25C |
increases expression |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of CDC25C protein |
CTD |
PMID:38521250 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases expression |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of CDK1 protein |
CTD |
PMID:38521250 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased expression of CDKN1A protein |
CTD |
PMID:38521250 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
decreases expression |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased expression of CDKN1B protein |
CTD |
PMID:38521250 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of CYCS protein |
CTD |
PMID:38521250 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression multiple interactions |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA] |
CTD |
PMID:31029725 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA] 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA; 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein |
CTD |
PMID:31029725 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein] |
CTD |
PMID:31029725 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of IL6 mRNA] |
CTD |
PMID:31029725 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased lipidation of and results in increased localization of MAP1LC3B protein; Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased lipidation of and results in increased localization of MAP1LC3B protein] |
CTD |
PMID:38521250 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:31029725 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:31029725 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation multiple interactions |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased phosphorylation of MAPK8 protein 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:31029725 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases phosphorylation multiple interactions |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased phosphorylation of MTOR protein Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:38521250 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects localization multiple interactions |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone affects the localization of NFE2L2 protein NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of IL6 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of TNF mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone affects the localization of NFE2L2 protein] |
CTD |
PMID:31029725 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of and affects the stability of NFKBIA protein] |
CTD |
PMID:31029725 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression multiple interactions |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA] |
CTD |
PMID:31029725 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression multiple interactions |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA] |
CTD |
PMID:31029725 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased cleavage of PARP1 protein] |
CTD |
PMID:38521250 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
multiple interactions decreases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in decreased phosphorylation of PIK3R1 protein] |
CTD |
PMID:38521250 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of SQSTM1 protein |
CTD |
PMID:38521250 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of TNF mRNA] |
CTD |
PMID:31029725 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
EXP |
2-nitroanisole results in increased expression of ALDH1A1 protein |
CTD |
PMID:33211169 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Cd44 |
CD44 molecule |
increases expression |
EXP |
2-nitroanisole results in increased expression of CD44 protein |
CTD |
PMID:33211169 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases metabolic processing increases oxidation increases expression |
ISO EXP |
CYP1A1 protein results in increased metabolism of 2-nitroanisole CYP1A1 protein results in increased oxidation of 2-nitroanisole 2-nitroanisole results in increased expression of CYP1A1 |
CTD |
PMID:11409192 PMID:15144223 PMID:17159769 PMID:21218109 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
EXP |
2-nitroanisole results in increased expression of CYP1A2; 2-nitroanisole results in increased expression of CYP1A2 protein |
CTD |
PMID:11409192 PMID:16601807 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases oxidation |
EXP |
CYP2B2 protein results in increased oxidation of 2-nitroanisole |
CTD |
PMID:21218109 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases oxidation increases metabolic processing |
ISO |
CYP2B6 protein results in increased oxidation of 2-nitroanisole CYP2B6 protein results in increased metabolism of 2-nitroanisole |
CTD |
PMID:15144223 PMID:17159769 PMID:21218109 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
increases oxidation |
EXP ISO |
CYP2C6 protein results in increased oxidation of 2-nitroanisole CYP2C19 protein results in increased oxidation of 2-nitroanisole |
CTD |
PMID:21218109 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2d2 |
cytochrome P450, family 2, subfamily d, polypeptide 2 |
increases oxidation |
EXP |
CYP2D2 protein results in increased oxidation of 2-nitroanisole |
CTD |
PMID:21218109 |
|
NCBI chr 7:113,935,138...113,939,209
Ensembl chr 7:113,935,138...113,939,209
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases metabolic processing increases oxidation |
ISO EXP |
CYP2E1 protein results in increased metabolism of 2-nitroanisole CYP2E1 protein results in increased oxidation of 2-nitroanisole |
CTD |
PMID:15144223 PMID:17159769 PMID:21218109 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
EXP |
2-nitroanisole results in increased expression of H2AX protein |
CTD |
PMID:26338220 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Krt14 |
keratin 14 |
increases expression |
EXP |
2-nitroanisole results in increased expression of KRT14 protein |
CTD |
PMID:33211169 |
|
NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
EXP |
2-nitroanisole results in increased expression of NQO1 |
CTD |
PMID:11409192 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Xdh |
xanthine dehydrogenase |
increases reduction |
ISO |
XDH protein results in increased reduction of 2-nitroanisole |
CTD |
PMID:14729594 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Taar1 |
trace-amine-associated receptor 1 |
increases activity multiple interactions |
ISO |
3-methoxytyramine results in increased activity of TAAR1 protein [3-methoxytyramine results in increased activity of TAAR1 protein] which results in increased abundance of Cyclic AMP |
CTD |
PMID:19725810 |
|
NCBI chr 1:21,517,742...21,518,740
Ensembl chr 1:21,517,258...21,532,084
|
|
G |
Vdr |
vitamin D receptor |
multiple interactions increases abundance |
ISO |
Calcitriol promotes the reaction [VDR protein results in increased abundance of 3-methoxytyramine] |
CTD |
PMID:27450565 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
4-acetylanisole results in increased expression of HMOX1 mRNA |
CTD |
PMID:26244607 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
|
G |
Taar1 |
trace-amine-associated receptor 1 |
increases activity multiple interactions |
ISO |
3-hydroxy-4-methoxyphenethylamine results in increased activity of TAAR1 protein [3-hydroxy-4-methoxyphenethylamine results in increased activity of TAAR1 protein] which results in increased abundance of Cyclic AMP |
CTD |
PMID:19725810 |
|
NCBI chr 1:21,517,742...21,518,740
Ensembl chr 1:21,517,258...21,532,084
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions increases expression |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [shogaol results in increased expression of ADIPOQ mRNA]; shogaol inhibits the reaction [TNF protein results in decreased expression of and results in decreased secretion of ADIPOQ protein] |
CTD |
PMID:18577375 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
shogaol metabolite results in increased expression of AKR1B10 protein; shogaol results in increased expression of AKR1B10 mRNA; shogaol results in increased expression of AKR1B10 protein |
CTD |
PMID:25148906 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions affects phosphorylation |
ISO |
shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of AKT1 protein] shogaol affects the phosphorylation of AKT1 protein AKT activator SC79 affects the reaction [shogaol affects the phosphorylation of AKT1 protein] |
CTD |
PMID:18683823 PMID:36341865 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions affects folding |
ISO |
shogaol results in increased expression of BAX protein shogaol promotes the reaction [BAX protein binds to BAX protein binds to BAX protein]; shogaol promotes the reaction [BAX protein binds to BAX protein] shogaol affects the folding of BAX protein |
CTD |
PMID:18384088 PMID:25619640 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
shogaol results in decreased expression of BCL2 protein |
CTD |
PMID:18384088 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
shogaol results in decreased expression of BCL2L1 protein |
CTD |
PMID:18384088 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions increases expression |
ISO |
[shogaol co-treated with Hydrogen Peroxide] results in increased expression of BDNF mRNA; [shogaol co-treated with Hydrogen Peroxide] results in increased expression of BDNF protein; shogaol inhibits the reaction [Hydrogen Peroxide results in decreased expression of BDNF mRNA] [shogaol results in increased expression of BDNF protein] which results in increased expression of CHAT protein; [shogaol results in increased expression of BDNF protein] which results in increased expression of SLC5A7 protein |
CTD |
PMID:22381256 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
[shogaol co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[shogaol co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein]; shogaol results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:18384088 PMID:25619640 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
shogaol results in increased cleavage of and results in increased activity of CASP9 protein |
CTD |
PMID:18384088 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases expression |
ISO |
shogaol results in decreased expression of CAT mRNA; shogaol results in decreased expression of CAT protein |
CTD |
PMID:36341865 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cdh1 |
cadherin 1 |
increases expression multiple interactions |
ISO |
shogaol results in increased expression of CDH1 mRNA; shogaol results in increased expression of CDH1 protein ferrostatin-1 inhibits the reaction [shogaol results in increased expression of CDH1 protein] |
CTD |
PMID:36341865 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh2 |
cadherin 2 |
decreases expression affects expression |
ISO |
shogaol results in decreased expression of CDH2 protein shogaol affects the expression of CDH2 mRNA |
CTD |
PMID:36341865 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [shogaol results in decreased expression of CFLAR protein modified form]; CFLAR protein modified form inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]]; shogaol promotes the reaction [Cycloheximide results in decreased expression of CFLAR protein modified form]; shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form] |
CTD |
PMID:25619640 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chat |
choline O-acetyltransferase |
multiple interactions increases expression |
ISO |
[shogaol co-treated with Hydrogen Peroxide] results in increased expression of CHAT protein; shogaol inhibits the reaction [Hydrogen Peroxide results in decreased expression of CHAT protein]; staurosporine aglycone inhibits the reaction [[shogaol co-treated with Hydrogen Peroxide] results in increased expression of CHAT protein] [shogaol results in increased expression of BDNF protein] which results in increased expression of CHAT protein; shogaol results in increased expression of CHAT protein |
CTD |
PMID:22381256 |
|
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
|
|
G |
Chuk |
component of inhibitor of nuclear factor kappa B kinase complex |
multiple interactions |
ISO |
shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased expression of CHUK protein] |
CTD |
PMID:23899529 |
|
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
|
|
G |
Ctnnb1 |
catenin beta 1 |
decreases expression |
ISO |
shogaol results in decreased expression of CTNNB1 mRNA; shogaol results in decreased expression of CTNNB1 protein |
CTD |
PMID:27645308 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [shogaol results in increased expression of DDIT3 mRNA]; Acetylcysteine inhibits the reaction [shogaol results in increased expression of DDIT3 protein] shogaol results in increased expression of DDIT3 mRNA; shogaol results in increased expression of DDIT3 protein |
CTD |
PMID:18384088 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dffa |
DNA fragmentation factor subunit alpha |
increases degradation |
ISO |
shogaol results in increased degradation of DFFA protein |
CTD |
PMID:18384088 |
|
NCBI chr 5:159,540,715...159,553,639
Ensembl chr 5:159,540,715...159,553,633
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions increases expression |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [shogaol results in increased expression of FABP4 mRNA] |
CTD |
PMID:18577375 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
shogaol results in increased expression of FAS protein |
CTD |
PMID:18384088 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression |
ISO |
shogaol results in increased expression of FASLG protein |
CTD |
PMID:18384088 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
decreases expression |
ISO |
shogaol results in decreased expression of FLT1 protein |
CTD |
PMID:36341865 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
ISO |
shogaol metabolite results in increased expression of FTL protein; shogaol results in increased expression of FTL mRNA; shogaol results in increased expression of FTL protein |
CTD |
PMID:25148906 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression multiple interactions |
ISO |
shogaol metabolite results in increased expression of GCLC protein; shogaol results in increased expression of GCLC protein shogaol results in increased expression of GCLC mRNA NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of GCLC mRNA] |
CTD |
PMID:25148906 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
shogaol metabolite results in increased expression of GCLM protein; shogaol results in increased expression of GCLM protein |
CTD |
PMID:25148906 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression |
ISO |
shogaol results in increased expression of GDF15 mRNA |
CTD |
PMID:25148906 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases expression multiple interactions |
ISO |
shogaol results in decreased expression of GPX4 mRNA; shogaol results in decreased expression of GPX4 protein ferrostatin-1 inhibits the reaction [shogaol results in decreased expression of GPX4 protein] |
CTD |
PMID:36341865 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
ISO |
shogaol results in increased expression of and results in increased phosphorylation of GSK3B protein |
CTD |
PMID:27645308 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions |
ISO |
shogaol analog inhibits the reaction [Doxorubicin results in increased phosphorylation of H2AX protein] |
CTD |
PMID:23899529 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite results in increased expression of HMOX1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol results in increased expression of HMOX1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite results in increased expression of HMOX1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol results in increased expression of HMOX1 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol metabolite results in increased expression of HMOX1 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol results in increased expression of HMOX1 protein] shogaol analog results in increased expression of HMOX1 protein; shogaol results in increased expression of HMOX1 protein KEAP1 protein affects the reaction [shogaol analog results in increased expression of HMOX1 protein]; NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of HMOX1 protein] shogaol analog results in increased expression of HMOX1 protein; shogaol metabolite results in increased expression of HMOX1 protein; shogaol results in increased expression of HMOX1 mRNA; shogaol results in increased expression of HMOX1 protein |
CTD |
PMID:23899529 PMID:25148906 PMID:36341865 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO |
shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased expression of IKBKB protein] |
CTD |
PMID:23899529 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
shogaol inhibits the reaction [IL1B protein results in increased expression of PTGES protein] |
CTD |
PMID:27645308 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions increases alkylation decreases expression |
ISO |
KEAP1 protein affects the reaction [shogaol analog results in increased expression of HMOX1 protein]; KEAP1 protein affects the reaction [shogaol analog results in increased expression of NFE2L2 protein]; KEAP1 protein affects the reaction [shogaol analog results in increased expression of NQO1 protein] shogaol results in increased alkylation of KEAP1 protein shogaol metabolite results in decreased expression of KEAP1 protein; shogaol results in decreased expression of KEAP1 protein |
CTD |
PMID:23899529 PMID:25148906 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] shogaol results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:18683823 PMID:36341865 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions decreases phosphorylation |
ISO |
shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] shogaol results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:18683823 PMID:36341865 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
affects expression multiple interactions decreases expression |
ISO |
shogaol affects the expression of MMP2 mRNA AKT activator SC79 inhibits the reaction [shogaol results in decreased expression of MMP2 protein] |
CTD |
PMID:36341865 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
ISO |
shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased secretion of MMP9 protein]; shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] shogaol results in decreased expression of MMP9 mRNA; shogaol results in decreased expression of MMP9 protein |
CTD |
PMID:23899529 PMID:36341865 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mt1 |
metallothionein 1 |
multiple interactions increases expression |
ISO |
NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of MT1 mRNA]; NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of MT1 protein] shogaol results in increased expression of MT1 mRNA; shogaol results in increased expression of MT1 protein |
CTD |
PMID:25148906 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression affects localization multiple interactions |
ISO |
shogaol analog results in increased expression of NFE2L2 protein shogaol affects the localization of NFE2L2 protein KEAP1 protein affects the reaction [shogaol analog results in increased expression of NFE2L2 protein]; NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of GCLC mRNA]; NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of HMOX1 protein]; NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of MT1 mRNA]; NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of MT1 protein] shogaol affects the localization of NFE2L2 protein; shogaol metabolite affects the localization of NFE2L2 protein; shogaol metabolite affects the localization of NFE2L2 protein modified form 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein modified form]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein modified form]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol affects the localization of and results in increased phosphorylation of NFE2L2 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein modified form]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [shogaol metabolite affects the localization of NFE2L2 protein]; shogaol metabolite results in increased expression of and results in increased phosphorylation of NFE2L2 protein; shogaol results in increased expression of and results in increased phosphorylation of NFE2L2 protein |
CTD |
PMID:23899529 PMID:25148906 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
shogaol inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein]; shogaol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] |
CTD |
PMID:18683823 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased expression of NFKBIA protein] shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein] |
CTD |
PMID:18683823 PMID:23899529 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; shogaol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] |
CTD |
PMID:18683823 PMID:23899529 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions increases expression |
ISO |
KEAP1 protein affects the reaction [shogaol analog results in increased expression of NQO1 protein] |
CTD |
PMID:23899529 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; Acetylcysteine inhibits the reaction [shogaol results in increased cleavage of PARP1 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; CFLAR protein modified form inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] |
CTD |
PMID:18384088 PMID:25619640 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases activity |
ISO |
shogaol results in increased activity of PPARG protein |
CTD |
PMID:18577375 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ptges |
prostaglandin E synthase |
multiple interactions decreases expression |
ISO |
shogaol inhibits the reaction [IL1B protein results in increased expression of PTGES protein] shogaol results in decreased expression of PTGES mRNA |
CTD |
PMID:27645308 |
|
NCBI chr 3:14,177,892...14,189,236
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; shogaol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; shogaol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] |
CTD |
PMID:18683823 PMID:23899529 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
shogaol inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]; shogaol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]; shogaol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein] shogaol analog inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RELA protein] |
CTD |
PMID:18683823 PMID:23899529 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Slc5a7 |
solute carrier family 5 member 7 |
multiple interactions increases expression |
ISO |
[shogaol co-treated with Hydrogen Peroxide] results in increased expression of SLC5A7 protein; shogaol inhibits the reaction [Hydrogen Peroxide results in decreased expression of SLC5A7 protein]; staurosporine aglycone inhibits the reaction [[shogaol co-treated with Hydrogen Peroxide] results in increased expression of SLC5A7 protein] [shogaol results in increased expression of BDNF protein] which results in increased expression of SLC5A7 protein; shogaol results in increased expression of SLC5A7 protein |
CTD |
PMID:22381256 |
|
NCBI chr 9:7,595,440...7,626,258
Ensembl chr 9:7,595,444...7,626,258
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
decreases expression |
ISO |
shogaol results in decreased expression of SLC7A11 mRNA; shogaol results in decreased expression of SLC7A11 protein |
CTD |
PMID:36341865 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Sod2 |
superoxide dismutase 2 |
decreases expression |
ISO |
shogaol results in decreased expression of SOD2 mRNA; shogaol results in decreased expression of SOD2 protein |
CTD |
PMID:36341865 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
shogaol inhibits the reaction [TNF protein results in decreased expression of and results in decreased secretion of ADIPOQ protein] |
CTD |
PMID:18577375 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions increases response to substance |
ISO |
[shogaol co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein; Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]]; Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[shogaol co-treated with TNFSF10 protein] results in increased cleavage of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; CFLAR protein modified form inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]]; S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]; shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]; shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein] shogaol results in increased susceptibility to TNFSF10 protein |
CTD |
PMID:25619640 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Vim |
vimentin |
decreases expression multiple interactions |
ISO |
shogaol results in decreased expression of VIM mRNA; shogaol results in decreased expression of VIM protein ferrostatin-1 inhibits the reaction [shogaol results in decreased expression of VIM protein] |
CTD |
PMID:36341865 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
affects response to substance |
EXP |
ABCB1 protein affects the susceptibility to aliskiren |
CTD |
PMID:24388840 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Agt |
angiotensinogen |
multiple interactions decreases expression |
EXP ISO |
aliskiren inhibits the reaction [Indomethacin results in increased expression of AGT protein] aliskiren inhibits the reaction [microcystin RR results in increased expression of AGT protein] aliskiren results in decreased expression of AGT protein modified form |
CTD |
PMID:18829990 PMID:27645307 PMID:28330766 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Camk2d |
calcium/calmodulin-dependent protein kinase II delta |
multiple interactions |
EXP |
[Carvedilol co-treated with aliskiren] inhibits the reaction [Isoproterenol results in increased expression of CAMK2D protein]; aliskiren inhibits the reaction [Isoproterenol results in increased expression of CAMK2D protein] |
CTD |
PMID:26982530 |
|
NCBI chr 2:215,023,785...215,287,351
Ensembl chr 2:215,024,004...215,286,178
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
[Carvedilol co-treated with aliskiren] inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein]; aliskiren inhibits the reaction [Isoproterenol results in increased expression of CASP3 protein] |
CTD |
PMID:26982530 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ckm |
creatine kinase, M-type |
multiple interactions |
EXP |
[Carvedilol co-treated with aliskiren] inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of CKM protein]; aliskiren inhibits the reaction [Isoproterenol results in increased expression of and results in increased secretion of CKM protein] |
CTD |
PMID:26982530 |
|
NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity |
ISO |
aliskiren results in decreased activity of CYP1A1 protein |
CTD |
PMID:33814510 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
aliskiren inhibits the reaction [Indomethacin results in increased expression of IL1B mRNA] |
CTD |
PMID:27645307 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
EXP |
aliskiren inhibits the reaction [Indomethacin results in increased expression of PTGS1 mRNA] |
CTD |
PMID:27645307 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
aliskiren inhibits the reaction [Indomethacin results in increased expression of PTGS2 mRNA] |
CTD |
PMID:27645307 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ren |
renin |
multiple interactions decreases activity |
ISO EXP |
[aliskiren co-treated with Atenolol] results in decreased activity of REN protein [aliskiren co-treated with Carvedilol] inhibits the reaction [Isoproterenol results in increased activity of REN protein]; aliskiren inhibits the reaction [Indomethacin results in increased expression of REN protein]; aliskiren inhibits the reaction [Isoproterenol results in increased activity of REN protein] aliskiren results in decreased activity of REN protein |
CTD |
PMID:18957387 PMID:26982530 PMID:27645307 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
aliskiren inhibits the reaction [Indomethacin results in increased expression of TNF mRNA] |
CTD |
PMID:27645307 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
anethole inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:29191726 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
ISO |
anethole results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:21212515 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
anethole inhibits the reaction [Doxorubicin results in increased expression of BAX mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of BAX mRNA] |
CTD |
PMID:35430261 PMID:39029857 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP |
anethole inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of BCL2 mRNA] |
CTD |
PMID:35430261 PMID:39029857 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
anethole inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; anethole inhibits the reaction [Isoproterenol results in increased cleavage of CASP3 protein] |
CTD |
PMID:35430261 PMID:39029857 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
anethole inhibits the reaction [Doxorubicin results in increased cleavage of CASP9 protein]; anethole inhibits the reaction [Isoproterenol results in increased cleavage of CASP9 protein] |
CTD |
PMID:35430261 PMID:39029857 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
anethole inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; anethole inhibits the reaction [Isoproterenol results in decreased activity of CAT protein] |
CTD |
PMID:35430261 PMID:39029857 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cst3 |
cystatin C |
multiple interactions |
EXP |
anethole inhibits the reaction [Doxorubicin results in increased expression of CST3 protein] |
CTD |
PMID:39029857 |
|
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
anethole inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:29191726 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding multiple interactions |
ISO EXP |
anethole metabolite binds to ESR1 protein anethole analog binds to ESR1 protein anethole metabolite inhibits the reaction [Estradiol binds to ESR1 protein] |
CTD |
PMID:12818366 PMID:27420082 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
decreases activity |
EXP |
anethole analog results in decreased activity of GGT1 protein |
CTD |
PMID:20171274 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression |
EXP |
anethole results in increased expression of GSTA2 protein |
CTD |
PMID:8406240 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
multiple interactions |
EXP |
anethole inhibits the reaction [Doxorubicin results in increased expression of HAVCR1 protein] |
CTD |
PMID:39029857 |
|
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
anethole promotes the reaction [Isoproterenol results in increased expression of HMOX1 mRNA]; anethole promotes the reaction [Isoproterenol results in increased expression of HMOX1 protein] |
CTD |
PMID:35430261 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
decreases activity |
ISO |
anethole results in decreased activity of IKBKB protein |
CTD |
PMID:10871845 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
anethole inhibits the reaction [Doxorubicin results in increased expression of IL1B protein]; anethole inhibits the reaction [Isoproterenol results in increased expression of IL1B protein] |
CTD |
PMID:35430261 PMID:39029857 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
anethole inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA]; anethole inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 protein] |
CTD |
PMID:16531003 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
anethole inhibits the reaction [Doxorubicin results in increased expression of IL6 protein]; anethole inhibits the reaction [Isoproterenol results in increased expression of IL6 protein] |
CTD |
PMID:35430261 PMID:39029857 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions |
EXP |
anethole inhibits the reaction [Isoproterenol results in increased expression of KEAP1 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of KEAP1 protein] |
CTD |
PMID:35430261 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Lcn2 |
lipocalin 2 |
multiple interactions |
EXP |
anethole inhibits the reaction [Doxorubicin results in increased expression of LCN2 protein] |
CTD |
PMID:39029857 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
ISO |
anethole inhibits the reaction [TNF protein results in increased activity of MAP2K1 protein] |
CTD |
PMID:10871845 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
ISO |
anethole results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:21212515 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
ISO |
anethole results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:21212515 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
anethole inhibits the reaction [TNF protein results in increased activity of MAPK8 protein] |
CTD |
PMID:10871845 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression decreases activity |
ISO |
anethole results in decreased expression of MMP2 mRNA anethole results in decreased activity of MMP2 protein |
CTD |
PMID:21212515 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases activity decreases expression |
ISO |
anethole results in decreased activity of MMP9 protein anethole results in decreased expression of MMP9 mRNA |
CTD |
PMID:21212515 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
multiple interactions |
EXP |
anethole inhibits the reaction [Doxorubicin results in increased expression of MYD88 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of MYD88 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of MYD88 protein] |
CTD |
PMID:35430261 PMID:39029857 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 mRNA]; anethole promotes the reaction [Isoproterenol results in increased expression of NFE2L2 protein] |
CTD |
PMID:35430261 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO EXP |
anethole inhibits the reaction [Ceramides results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Hydrogen Peroxide results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Okadaic Acid results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] anethole inhibits the reaction [Doxorubicin results in increased expression of NFKB1 mRNA] |
CTD |
PMID:10871845 PMID:39029857 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions decreases degradation |
ISO |
anethole inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; anethole inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein] anethole results in decreased degradation of NFKBIA protein |
CTD |
PMID:10871845 PMID:21212515 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
anethole inhibits the reaction [TNF protein results in increased cleavage of PARP1 protein] |
CTD |
PMID:10871845 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Plau |
plasminogen activator, urokinase |
decreases expression |
ISO |
anethole results in decreased expression of PLAU mRNA |
CTD |
PMID:21212515 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO EXP |
anethole inhibits the reaction [Ceramides results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Hydrogen Peroxide results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [Okadaic Acid results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] anethole inhibits the reaction [Isoproterenol results in increased expression of RELA protein] |
CTD |
PMID:10871845 PMID:35430261 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
ISO |
anethole results in increased expression of TIMP1 mRNA |
CTD |
PMID:21212515 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
EXP |
anethole inhibits the reaction [Doxorubicin results in increased expression of TLR4 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of TLR4 mRNA]; anethole inhibits the reaction [Isoproterenol results in increased expression of TLR4 protein] |
CTD |
PMID:35430261 PMID:39029857 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
anethole inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]]; anethole inhibits the reaction [TNF protein results in increased activity of MAP2K1 protein]; anethole inhibits the reaction [TNF protein results in increased activity of MAPK8 protein]; anethole inhibits the reaction [TNF protein results in increased cleavage of PARP1 protein]; anethole inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]; anethole inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein] anethole inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; anethole inhibits the reaction [Isoproterenol results in increased expression of TNF protein] |
CTD |
PMID:10871845 PMID:35430261 PMID:39029857 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnni3 |
troponin I3, cardiac type |
multiple interactions |
EXP |
anethole inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein] |
CTD |
PMID:35430261 |
|
NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580
|
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
BI 2536 results in increased activity of CASP8 protein |
CTD |
PMID:24403256 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Notch1 |
notch receptor 1 |
multiple interactions |
ISO |
BI 2536 inhibits the reaction [Arsenic Trioxide results in decreased expression of NOTCH1 protein]; BI 2536 inhibits the reaction [Nocodazole results in decreased expression of NOTCH1 protein] |
CTD |
PMID:31597699 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Plk1 |
polo-like kinase 1 |
decreases activity multiple interactions |
ISO |
BI 2536 results in decreased activity of PLK1 protein BI 2536 inhibits the reaction [Arsenic Trioxide results in increased phosphorylation of PLK1 protein] |
CTD |
PMID:24748653 PMID:31597699 |
|
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
|
|
|
G |
Cd69 |
Cd69 molecule |
decreases localization |
ISO |
capsiate analog results in decreased localization of CD69 protein |
CTD |
PMID:12115659 |
|
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:162,725,446...162,733,542
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases localization |
ISO |
capsiate analog results in decreased localization of ICAM1 protein |
CTD |
PMID:12115659 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Igf1 |
insulin-like growth factor 1 |
increases expression |
ISO |
capsiate results in increased expression of IGF1 protein |
CTD |
PMID:17307377 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Ikbkg |
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
multiple interactions |
ISO |
capsiate analog inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Plant Preparations] results in increased activity of IKBKG protein] |
CTD |
PMID:12115659 |
|
NCBI chr X:152,216,485...152,241,476
Ensembl chr X:152,216,596...152,239,499
|
|
G |
Il2ra |
interleukin 2 receptor subunit alpha |
decreases localization |
ISO |
capsiate analog results in decreased localization of IL2RA protein |
CTD |
PMID:12115659 |
|
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
capsiate analog inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Plant Preparations] results in increased degradation of NFKBIA protein] |
CTD |
PMID:12115659 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Ucp3 |
uncoupling protein 3 |
decreases expression |
EXP |
capsiate results in decreased expression of UCP3 mRNA |
CTD |
PMID:17264228 |
|
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
increases expression |
ISO |
coniferaldehyde results in increased expression of ABCC2 mRNA |
CTD |
PMID:26275128 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
increases expression |
ISO |
coniferaldehyde results in increased expression of ABCC3 mRNA |
CTD |
PMID:26275128 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
multiple interactions increases expression |
ISO |
NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of AKR1C1 protein] coniferaldehyde results in increased expression of AKR1C1 mRNA; coniferaldehyde results in increased expression of AKR1C1 protein |
CTD |
PMID:26275128 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
coniferaldehyde results in increased expression of AKR1C2 mRNA; coniferaldehyde results in increased expression of AKR1C2 protein |
CTD |
PMID:26275128 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases expression |
ISO |
coniferaldehyde results in increased expression of AKR1C3 mRNA |
CTD |
PMID:26275128 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
coniferaldehyde results in increased expression of GCLC mRNA |
CTD |
PMID:26275128 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
coniferaldehyde results in increased expression of GCLM mRNA |
CTD |
PMID:26275128 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO |
coniferaldehyde results in increased expression of GSR mRNA coniferaldehyde results in increased expression of GSR protein |
CTD |
PMID:26275128 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; MAPK14 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; PKN3 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; Ro 31-8220 inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein] coniferaldehyde results in increased expression of HMOX1 mRNA; coniferaldehyde results in increased expression of HMOX1 protein |
CTD |
PMID:26275128 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein]; coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of JAK2 protein]; coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of STAT1 protein] |
CTD |
PMID:27378624 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
ISO |
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of JAK2 protein] coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of JAK2 protein] |
CTD |
PMID:27378624 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
MAPK14 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; MAPK14 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein] |
CTD |
PMID:26275128 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapkapk2 |
MAPK activated protein kinase 2 |
multiple interactions |
ISO |
MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein] |
CTD |
PMID:26275128 |
|
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
increases expression multiple interactions |
ISO |
coniferaldehyde results in increased expression of MUC5AC mRNA 2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [coniferaldehyde results in increased expression of MUC5AC mRNA]; A 967079 inhibits the reaction [coniferaldehyde results in increased expression of MUC5AC mRNA]; coniferaldehyde results in increased expression of and results in increased secretion of MUC5AC protein; TWS 119 inhibits the reaction [coniferaldehyde results in increased expression of MUC5AC mRNA] |
CTD |
PMID:31944254 |
|
NCBI chr 1:196,864,336...196,896,475
Ensembl chr 1:196,864,336...196,896,475
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions increases expression |
ISO |
coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein; MAPK14 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; MAPKAPK2 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of AKR1C1 protein]; NFE2L2 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]; PKN3 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein] coniferaldehyde results in increased expression of NFE2L2 protein |
CTD |
PMID:26275128 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein] coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA]; coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein] |
CTD |
PMID:27378624 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
coniferaldehyde results in increased expression of NQO1 protein |
CTD |
PMID:26275128 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Pkn3 |
protein kinase N3 |
multiple interactions |
ISO |
PKN3 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; PKN3 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein] |
CTD |
PMID:26275128 |
|
NCBI chr 3:13,350,082...13,363,572
Ensembl chr 3:13,335,041...13,363,567
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
multiple interactions |
ISO |
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of STAT1 protein] coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of STAT1 protein modified form]; coniferaldehyde inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of STAT1 protein] |
CTD |
PMID:27378624 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased expression of NOS2 protein]; coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of JAK2 protein]; coniferaldehyde inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased phosphorylation of STAT1 protein] |
CTD |
PMID:27378624 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
increases activity |
ISO |
coniferaldehyde results in increased activity of TRPA1 protein |
CTD |
PMID:23541125 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
coniferaldehyde results in increased expression of TXNRD1 mRNA |
CTD |
PMID:26275128 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
|
G |
Ednra |
endothelin receptor type A |
multiple interactions |
ISO |
enrasentan binds to and results in decreased activity of EDNRA protein |
CTD |
PMID:16219361 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Ednrb |
endothelin receptor type B |
multiple interactions |
ISO |
enrasentan binds to and results in decreased activity of EDNRB protein |
CTD |
PMID:16219361 |
|
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
estragole inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:29191726 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Casp3 |
caspase 3 |
increases expression |
EXP |
estragole results in increased expression of CASP3 protein modified form |
CTD |
PMID:29054680 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccna2 |
cyclin A2 |
increases expression |
EXP |
estragole results in increased expression of CCNA2 mRNA |
CTD |
PMID:29054680 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression multiple interactions |
EXP ISO |
estragole results in increased expression of CCNB1 mRNA flumequine promotes the reaction [estragole results in increased expression of CCNB1 mRNA] |
CTD |
PMID:29054680 PMID:31029721 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
EXP |
estragole results in increased expression of CCND1 protein |
CTD |
PMID:29054680 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
increases expression multiple interactions |
EXP ISO |
estragole results in increased expression of CCNE1 mRNA [flumequine co-treated with estragole] results in increased expression of CCNE1 mRNA |
CTD |
PMID:29054680 PMID:31029721 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Chek1 |
checkpoint kinase 1 |
increases expression |
EXP |
estragole results in increased expression of CHEK1 protein |
CTD |
PMID:29054680 |
|
NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
estragole inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] |
CTD |
PMID:29191726 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases hydroxylation increases response to substance multiple interactions increases expression |
ISO |
CYP1A2 protein results in increased hydroxylation of estragole CYP1A2 protein results in increased susceptibility to estragole [flumequine co-treated with estragole] results in increased expression of CYP1A2 mRNA estragole results in increased expression of CYP1A2 mRNA |
CTD |
PMID:19920071 PMID:31029721 PMID:32853702 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases hydroxylation |
ISO |
CYP2E1 protein results in increased hydroxylation of estragole |
CTD |
PMID:19920071 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases phosphorylation |
EXP |
estragole results in increased phosphorylation of GSK3B protein |
CTD |
PMID:29054680 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
EXP |
estragole results in increased expression of H2AX protein modified form |
CTD |
PMID:29054680 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
EXP |
estragole results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:29054680 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
EXP |
estragole results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:29054680 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation |
EXP |
estragole results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:29054680 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
EXP |
estragole results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:29054680 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression |
EXP |
estragole results in increased expression of PCNA protein |
CTD |
PMID:22576464 PMID:29054680 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Ppp2ca |
protein phosphatase 2 catalytic subunit alpha |
increases phosphorylation |
EXP |
estragole results in increased phosphorylation of PPP2CA protein |
CTD |
PMID:29054680 |
|
NCBI chr10:36,358,110...36,377,864
Ensembl chr10:36,358,101...36,377,862
|
|
G |
Rad51 |
RAD51 recombinase |
increases expression |
EXP |
estragole results in increased expression of RAD51 protein |
CTD |
PMID:29054680 |
|
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
increases phosphorylation |
EXP |
estragole results in increased phosphorylation of SRC protein |
CTD |
PMID:29054680 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
[flumequine co-treated with estragole] results in increased expression of TNF mRNA |
CTD |
PMID:31029721 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases phosphorylation |
EXP |
estragole results in increased phosphorylation of TP53 protein |
CTD |
PMID:29054680 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions |
ISO |
[flumequine co-treated with estragole] results in decreased expression of UGT1A1 mRNA |
CTD |
PMID:31029721 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
|
G |
Or5d18 |
olfactory receptor family 5 subfamily D member 18 |
multiple interactions |
ISO |
[ethyl vanillin binds to and results in increased activity of OR5D18 protein] which results in increased transport of Calcium; ethyl vanillin binds to and results in increased activity of OR5D18 protein |
CTD |
PMID:15716417 |
|
NCBI chr 3:73,516,522...73,517,463
Ensembl chr 3:73,516,364...73,519,858 Ensembl chr 3:73,516,364...73,519,858
|
|
G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
increases activity |
ISO |
ethyl vanillin results in increased activity of TRPV3 protein |
CTD |
PMID:16617338 |
|
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
|
|
|
G |
Abca6 |
ATP binding cassette subfamily A member 6 |
decreases expression |
ISO |
Eugenol results in decreased expression of ABCA6 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr10:95,142,805...95,212,087
Ensembl chr10:95,142,966...95,211,530
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Chlorpyrifos results in decreased expression of ACHE protein] |
CTD |
PMID:32096903 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions increases activity affects localization |
ISO |
[Eugenol co-treated with acetyleugenol] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]; [Eugenol co-treated with acetyleugenol] results in increased activity of AHR protein; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein]; Eugenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] Eugenol results in increased activity of AHR protein Eugenol affects the localization of AHR protein |
CTD |
PMID:17275817 PMID:22686307 PMID:29191726 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
increases expression |
ISO |
Eugenol results in increased expression of AHRR mRNA |
CTD |
PMID:22686307 |
|
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases expression |
ISO |
Eugenol results in increased expression of AKR1B1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
Eugenol results in increased expression of AKR1B10 mRNA |
CTD |
PMID:20566472 PMID:26198647 PMID:30806763 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
Eugenol results in increased expression of AKR1C1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Eugenol results in increased expression of AKR1C2 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases expression |
ISO |
Eugenol results in increased expression of AKR1C3 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Alb |
albumin |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Streptozocin results in decreased expression of ALB protein] |
CTD |
PMID:38047382 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression |
ISO |
Eugenol results in increased expression of ALPL mRNA |
CTD |
PMID:22083529 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of APAF1 protein] |
CTD |
PMID:20434464 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Eugenol binds to and results in decreased activity of AR protein |
CTD |
PMID:20226658 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arhgap17 |
Rho GTPase activating protein 17 |
decreases expression |
ISO |
Eugenol results in decreased expression of ARHGAP17 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:177,807,579...177,897,027
Ensembl chr 1:177,807,583...177,896,854
|
|
G |
Arl4c |
ARF like GTPase 4C |
increases expression |
ISO |
Eugenol results in increased expression of ARL4C mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
Eugenol results in increased expression of ATF3 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
B2m |
beta-2 microglobulin |
increases expression |
ISO |
Eugenol results in increased expression of B2M mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAD mRNA] |
CTD |
PMID:20434464 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BAX protein] Eugenol results in increased expression of BAX mRNA |
CTD |
PMID:20434464 PMID:20537511 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
[Eugenol results in increased activity of sulforaphane] which results in decreased expression of BCL2; [sulforaphane results in increased activity of Eugenol] which results in decreased expression of BCL2 Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein] Eugenol results in decreased expression of BCL2 mRNA |
CTD |
PMID:20434464 PMID:20537511 PMID:21382956 PMID:21939359 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA] |
CTD |
PMID:20434464 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bclaf1 |
BCL2-associated transcription factor 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of BCLAF1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:15,088,436...15,117,666
Ensembl chr 1:15,070,894...15,148,832
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
ISO |
Eugenol results in increased expression of BDNF mRNA |
CTD |
PMID:15157811 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BID mRNA] |
CTD |
PMID:20434464 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
increases expression |
ISO |
Eugenol results in increased expression of BMP6 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
decreases expression |
ISO |
Eugenol results in decreased expression of BUB1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Calcrl |
calcitonin receptor like receptor |
increases expression |
ISO |
Eugenol results in increased expression of CALCRL mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 3:69,428,348...69,525,910
Ensembl chr 3:69,430,120...69,525,910
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases activity increases cleavage |
ISO EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP3 protein] Eugenol results in increased expression of CASP3 mRNA Eugenol results in increased activity of CASP3 protein Eugenol inhibits the reaction [Chlorpyrifos results in increased expression of CASP3 protein]; Eugenol inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein] Eugenol results in increased expression of CASP3 protein modified form Eugenol results in increased cleavage of CASP3 protein |
CTD |
PMID:20434464 PMID:20537511 PMID:21656368 PMID:25455450 PMID:30518369 PMID:32096903 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases expression |
ISO |
Eugenol results in increased expression of CASP7 mRNA |
CTD |
PMID:30518369 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression increases activity |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CASP9 protein] Eugenol results in increased expression of CASP9 mRNA Eugenol results in increased activity of CASP9 protein |
CTD |
PMID:20434464 PMID:25455450 PMID:30518369 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases expression decreases activity multiple interactions |
ISO EXP |
Eugenol results in increased expression of CAT mRNA Eugenol results in decreased activity of CAT protein Eugenol inhibits the reaction [Acetic Acid results in increased activity of CAT protein]; Eugenol inhibits the reaction [Chlorpyrifos results in decreased expression of CAT protein] CAT protein inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol] |
CTD |
PMID:15576237 PMID:20566472 PMID:32096903 PMID:33245926 PMID:36007673 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl12 |
C-C motif chemokine ligand 12 |
increases expression |
ISO |
Eugenol results in increased expression of CCL13 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
increases expression |
ISO |
Eugenol results in increased expression of CCL19 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression increases secretion decreases expression |
ISO |
Eugenol results in increased expression of CCL2 mRNA Eugenol results in increased secretion of CCL2 protein Eugenol results in decreased expression of CCL2 mRNA |
CTD |
PMID:15585374 PMID:17374397 PMID:17936526 PMID:22245253 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
ISO |
Eugenol results in increased expression of CCL20 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression increases secretion |
ISO |
Eugenol results in increased expression of CCL3 mRNA Eugenol results in increased secretion of CCL3 protein |
CTD |
PMID:15585374 PMID:23624239 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression increases secretion |
ISO |
Eugenol results in increased expression of CCL4 mRNA; Eugenol results in increased expression of CCL4 protein Eugenol results in increased secretion of CCL4 protein |
CTD |
PMID:15585374 PMID:18353026 PMID:30806763 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCNB1 mRNA] |
CTD |
PMID:19851710 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CCND1 mRNA] |
CTD |
PMID:19851710 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
decreases expression |
ISO |
Eugenol results in decreased expression of CCR2 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 8:123,734,465...123,742,483
Ensembl chr 8:123,734,430...123,742,100
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
increases expression |
ISO |
Eugenol results in increased expression of CCR5 mRNA |
CTD |
PMID:17936526 PMID:20713136 |
|
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
increases expression |
ISO |
Eugenol results in increased expression of CCR7 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309
|
|
G |
Cd24 |
CD24 molecule |
decreases expression |
ISO |
Eugenol results in decreased expression of CD24 protein |
CTD |
PMID:31926151 |
|
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
|
|
G |
Cd274 |
CD274 molecule |
increases expression |
ISO |
Eugenol results in increased expression of CD274 protein |
CTD |
PMID:23624239 |
|
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cd36 |
CD36 molecule |
decreases expression |
ISO |
Eugenol results in decreased expression of CD36 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cd44 |
CD44 molecule |
decreases expression |
ISO |
Eugenol results in decreased expression of CD44 protein |
CTD |
PMID:31926151 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions increases expression |
ISO |
[Dicumarol results in decreased activity of NQO1 protein] inhibits the reaction [Eugenol results in increased expression of CD86 protein] |
CTD |
PMID:12423654 PMID:20488241 PMID:21742781 PMID:23624239 PMID:30806763 |
|
NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
Eugenol results in decreased expression of CDK6 protein |
CTD |
PMID:22686307 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO EXP |
Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1A protein] |
CTD |
PMID:19851710 PMID:20043298 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
Eugenol results in increased expression of CDKN1B protein |
CTD |
PMID:22686307 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cish |
cytokine inducible SH2-containing protein |
decreases expression |
ISO |
Eugenol results in decreased expression of CISH mRNA |
CTD |
PMID:15618236 |
|
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
|
|
G |
Clec4a3 |
C-type lectin domain family 4, member A3 |
decreases expression |
ISO |
Eugenol results in decreased expression of CLEC4A protein |
CTD |
PMID:23624239 |
|
NCBI chr 4:156,214,030...156,224,818
Ensembl chr 4:156,214,718...156,224,817
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
affects expression |
ISO |
Eugenol affects the expression of CREB1 mRNA |
CTD |
PMID:20385217 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crem |
cAMP responsive element modulator |
increases expression |
ISO |
Eugenol results in increased expression of CREM mRNA |
CTD |
PMID:17374397 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions decreases expression |
ISO |
Eugenol results in decreased expression of and affects the phosphorylation of and affects the localization of CTNNB1 protein Eugenol results in decreased expression of CTNNB1 mRNA |
CTD |
PMID:31926151 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctsl |
cathepsin L |
increases expression |
ISO |
Eugenol results in increased expression of CTSL mRNA |
CTD |
PMID:17374397 |
|
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
increases expression |
ISO |
Eugenol results in increased expression of CXCL1 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
increases expression multiple interactions |
ISO |
Eugenol results in increased expression of CXCL1 mRNA Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 mRNA] |
CTD |
PMID:12963494 PMID:20713136 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
increases expression |
ISO |
Eugenol results in increased expression of CXCR4 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CYCS protein] |
CTD |
PMID:20434464 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression decreases expression decreases activity |
ISO |
[CYP1A1 protein co-treated with Copper] results in increased activity of Eugenol; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; Eugenol inhibits the reaction [CYP1A1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene]; Eugenol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] Eugenol results in increased expression of CYP1A1 mRNA Eugenol results in decreased expression of CYP1A1 mRNA Eugenol results in decreased activity of CYP1A1 protein |
CTD |
PMID:15576237 PMID:17275817 PMID:20713136 PMID:22686307 PMID:29191726 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[CYP1A2 protein co-treated with Copper] results in increased activity of Eugenol |
CTD |
PMID:15576237 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions decreases activity |
ISO |
Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; Eugenol inhibits the reaction [CYP1B1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene] Eugenol results in decreased activity of CYP1B1 protein |
CTD |
PMID:17275817 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of CYP27A1 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
multiple interactions increases metabolic processing |
ISO |
[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol; [CYP2D6 protein results in increased metabolism of Eugenol] which results in increased abundance of 2-hydroxychavicol; [Eugenol co-treated with Copper co-treated with CYP2D6 protein] results in increased abundance of 8-Hydroxy-2'-Deoxyguanosine; bathocuproine inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol]; CAT protein inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol]; methional inhibits the reaction [[CYP2D6 protein co-treated with Copper] results in increased activity of Eugenol] |
CTD |
PMID:15576237 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP ISO |
Eugenol inhibits the reaction [Thioacetamide results in increased expression of CYP2E1 protein] [CYP2E1 protein co-treated with Copper] results in increased activity of Eugenol |
CTD |
PMID:15576237 PMID:20036707 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Dkc1 |
dyskerin pseudouridine synthase 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of DKC1 mRNA |
CTD |
PMID:17374397 |
|
|
|
G |
Dlgap5 |
DLG associated protein 5 |
decreases expression |
ISO |
Eugenol results in decreased expression of DLGAP5 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
Eugenol results in increased expression of DNAJB4 mRNA |
CTD |
PMID:23999411 PMID:27965148 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnase2 |
deoxyribonuclease 2, lysosomal |
increases expression |
ISO |
Eugenol results in increased expression of DNASE2A mRNA |
CTD |
PMID:15618236 |
|
NCBI chr19:23,244,656...23,247,376
Ensembl chr19:23,244,664...23,247,376
|
|
G |
Drd1 |
dopamine receptor D1 |
multiple interactions |
EXP |
[2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine binds to and results in increased activity of DRD1 protein] which results in increased susceptibility to Eugenol |
CTD |
PMID:9537685 |
|
NCBI chr17:10,540,440...10,544,971
Ensembl chr17:10,540,558...10,545,002
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
increases expression |
ISO |
Eugenol results in increased expression of DUSP1 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of E2F1 mRNA; Eugenol results in decreased expression of E2F1 protein |
CTD |
PMID:15574415 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f2 |
E2F transcription factor 2 |
decreases expression |
ISO |
Eugenol results in decreased expression of E2F2 mRNA; Eugenol results in decreased expression of E2F2 protein |
CTD |
PMID:15574415 |
|
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
|
|
G |
E2f3 |
E2F transcription factor 3 |
decreases expression |
ISO |
Eugenol results in decreased expression of E2F3 mRNA; Eugenol results in decreased expression of E2F3 protein |
CTD |
PMID:15574415 |
|
NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
|
|
G |
E2f4 |
E2F transcription factor 4 |
decreases expression |
ISO |
Eugenol results in decreased expression of E2F4 mRNA |
CTD |
PMID:15574415 |
|
NCBI chr19:33,174,396...33,181,806
Ensembl chr19:33,174,410...33,181,806
|
|
G |
E2f5 |
E2F transcription factor 5 |
decreases expression |
ISO |
Eugenol results in decreased expression of E2F5 mRNA |
CTD |
PMID:15574415 |
|
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
|
|
G |
E2f6 |
E2F transcription factor 6 |
increases expression |
ISO |
Eugenol results in increased expression of E2F6 mRNA |
CTD |
PMID:15574415 |
|
NCBI chr 6:39,592,224...39,608,685
Ensembl chr 6:39,592,228...39,608,683
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression increases expression |
ISO |
Eugenol results in decreased expression of EGFR protein Eugenol results in increased expression of EGFR mRNA |
CTD |
PMID:15618236 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
ISO |
[[Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP] which results in increased expression of EGR1 mRNA |
CTD |
PMID:12767924 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Egr2 |
early growth response 2 |
decreases expression |
ISO |
Eugenol results in decreased expression of EGR2 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
|
|
G |
Emb |
embigin |
decreases expression |
ISO |
Eugenol results in decreased expression of EMB mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050
|
|
G |
Epcam |
epithelial cell adhesion molecule |
decreases expression |
ISO |
Eugenol results in decreased expression of EPCAM protein Eugenol results in decreased expression of EPCAM mRNA; Eugenol results in decreased expression of EPCAM protein |
CTD |
PMID:31926151 |
|
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding multiple interactions |
ISO |
Eugenol binds to ESR1 protein Eugenol inhibits the reaction [Estradiol binds to ESR1 protein] |
CTD |
PMID:12495555 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
affects binding multiple interactions |
ISO |
Eugenol binds to ESR2 protein Eugenol inhibits the reaction [Estradiol binds to ESR2 protein] |
CTD |
PMID:12495555 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
F13a1 |
coagulation factor XIII A1 chain |
decreases expression |
ISO |
Eugenol results in decreased expression of F13A1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
Eugenol results in decreased expression of FASN mRNA |
CTD |
PMID:21870829 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbxo9 |
f-box protein 9 |
decreases expression |
ISO |
Eugenol results in decreased expression of FBXO9 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 8:78,958,482...78,984,015
Ensembl chr 8:78,958,483...78,983,949
|
|
G |
Fcgr2b |
Fc gamma receptor 2B |
increases expression |
ISO |
Eugenol results in increased expression of FCGR2B mRNA |
CTD |
PMID:17374397 |
|
NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778
|
|
G |
Fech |
ferrochelatase |
increases expression |
ISO |
Eugenol results in increased expression of FECH mRNA |
CTD |
PMID:20566472 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Ferry3 |
FERRY endosomal RAB5 effector complex subunit 3 |
decreases expression |
ISO |
Eugenol results in decreased expression of FERRY3 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 4:159,772,693...159,809,322
Ensembl chr 4:159,772,786...159,806,382
|
|
G |
Flt1 |
Fms related receptor tyrosine kinase 1 |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of FLT1 mRNA] |
CTD |
PMID:20434464 |
|
NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626
|
|
G |
Fosl2 |
FOS like 2, AP-1 transcription factor subunit |
increases expression |
ISO |
Eugenol results in increased expression of FOSL2 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
ISO |
Eugenol results in increased expression of FTL mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases expression |
ISO |
Eugenol results in increased expression of G6PD mRNA |
CTD |
PMID:20566472 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of GADD45A mRNA] |
CTD |
PMID:19851710 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
increases expression |
ISO |
Eugenol results in increased expression of GADD45B mRNA |
CTD |
PMID:15618236 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
Eugenol results in increased expression of GCLC mRNA |
CTD |
PMID:20566472 PMID:26198647 PMID:30806763 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
Eugenol results in increased expression of GCLM mRNA |
CTD |
PMID:20566472 PMID:26198647 PMID:27965148 PMID:30806763 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gpat3 |
glycerol-3-phosphate acyltransferase 3 |
increases expression |
ISO |
Eugenol results in increased expression of GPAT3 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr14:8,715,367...8,768,051
Ensembl chr14:8,714,373...8,766,490
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Streptozocin results in increased expression of GPT protein] |
CTD |
PMID:38047382 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
Eugenol results in increased expression of GPX3 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases expression |
ISO |
Eugenol results in increased expression of GSK3B mRNA |
CTD |
PMID:17374397 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO |
Eugenol results in increased expression of GSR mRNA |
CTD |
PMID:20566472 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
decreases activity |
ISO |
Eugenol analog results in decreased activity of GSTA1 protein |
CTD |
PMID:8620581 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression decreases activity |
EXP |
Eugenol results in increased expression of GSTA2 protein Eugenol analog results in decreased activity of GSTA2 protein |
CTD |
PMID:8406240 PMID:8620581 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
decreases activity |
EXP |
Eugenol analog results in decreased activity of GSTA3 protein |
CTD |
PMID:8620581 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
decreases activity |
ISO EXP |
Eugenol analog results in decreased activity of GSTM1 protein |
CTD |
PMID:8620581 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
decreases activity |
EXP |
Eugenol analog results in decreased activity of GSTM2 protein |
CTD |
PMID:8620581 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
decreases activity |
ISO EXP |
Eugenol analog results in decreased activity of GSTP1 protein |
CTD |
PMID:8620581 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Heatr5b |
HEAT repeat containing 5B |
decreases expression |
ISO |
Eugenol results in decreased expression of HEATR5B mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 6:16,243,424...16,323,444
Ensembl chr 6:16,243,461...16,323,435
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases expression |
ISO |
Eugenol results in increased expression of HIF1A mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
decreases expression |
ISO |
Eugenol results in decreased expression of HMGCR mRNA |
CTD |
PMID:21870829 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
Eugenol results in increased expression of HMOX1 mRNA |
CTD |
PMID:20566472 PMID:20713136 PMID:23445166 PMID:26244607 PMID:30806763 PMID:31967339 More...
|
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnrnpa3 |
heterogeneous nuclear ribonucleoprotein A3 |
decreases expression |
ISO |
Eugenol results in decreased expression of HNRNPA3 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 3:60,578,574...60,588,755
Ensembl chr 3:60,578,673...60,588,306
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
decreases expression |
ISO |
Eugenol results in decreased expression of HRAS protein |
CTD |
PMID:20537511 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression |
ISO |
Eugenol results in increased expression of HSPA6 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr13:83,273,176...83,274,317
|
|
G |
Hsph1 |
heat shock protein family H (Hsp110) member 1 |
increases expression |
ISO |
Eugenol results in increased expression of HSPH1 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
|
|
G |
Ibsp |
integrin-binding sialoprotein |
decreases expression |
ISO |
Eugenol results in decreased expression of IBSP mRNA; Eugenol results in decreased expression of IBSP protein |
CTD |
PMID:21706355 |
|
NCBI chr14:5,439,825...5,452,570
Ensembl chr14:5,439,829...5,452,693
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
increases expression |
ISO |
Eugenol results in increased expression of ICAM1 mRNA; Eugenol results in increased expression of ICAM1 protein |
CTD |
PMID:30806763 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of IDI1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr17:61,629,592...61,637,357
Ensembl chr17:61,629,594...61,637,357
|
|
G |
Ifng |
interferon gamma |
increases secretion multiple interactions |
ISO |
Eugenol results in increased secretion of IFNG protein [Methoxychlor co-treated with Eugenol] results in increased expression of IFNG protein; [Parathion co-treated with Eugenol] results in increased expression of IFNG protein |
CTD |
PMID:20920556 PMID:22245253 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of IKBKB protein] |
CTD |
PMID:19851710 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO |
[Eugenol co-treated with Acetylcysteine] inhibits the reaction [Nicotine results in decreased secretion of IL10 protein]; Eugenol inhibits the reaction [Nicotine results in decreased expression of IL10 mRNA] |
CTD |
PMID:21237301 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Nicotine results in increased secretion of [IL12A protein co-treated with IL12B protein]] |
CTD |
PMID:21237301 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
Eugenol inhibits the reaction [Nicotine results in increased expression of IL12B mRNA]; Eugenol inhibits the reaction [Nicotine results in increased secretion of [IL12A protein co-treated with IL12B protein]] |
CTD |
PMID:21237301 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il16 |
interleukin 16 |
multiple interactions increases secretion |
ISO |
Eugenol results in increased expression of and results in increased secretion of IL16 protein Eugenol results in increased secretion of IL16 protein |
CTD |
PMID:23624239 PMID:30806763 |
|
NCBI chr 1:137,617,702...137,718,022
Ensembl chr 1:137,617,944...137,718,130
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
Eugenol results in increased expression of IL18 protein |
CTD |
PMID:23063874 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
Eugenol results in increased expression of IL1A mRNA |
CTD |
PMID:30806763 PMID:33715048 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression decreases expression |
ISO |
[Eugenol results in increased activity of sulforaphane] which results in decreased expression of IL1B; [sulforaphane results in increased activity of Eugenol] which results in decreased expression of IL1B; Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of IL1B protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of IL1B protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] Eugenol results in increased expression of IL1B mRNA Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein] Eugenol results in decreased expression of IL1B mRNA |
CTD |
PMID:12963494 PMID:17509409 PMID:20713136 PMID:21382956 PMID:21807015 PMID:21939359 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
increases expression |
ISO |
Eugenol results in increased expression of IL1R2 mRNA |
CTD |
PMID:20713136 PMID:30806763 |
|
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il2 |
interleukin 2 |
increases expression increases secretion |
ISO |
Eugenol results in increased expression of IL2 protein Eugenol results in increased secretion of IL2 protein |
CTD |
PMID:22245253 PMID:22381623 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il4r |
interleukin 4 receptor |
increases expression |
ISO |
Eugenol results in increased expression of IL4RA protein |
CTD |
PMID:22381623 |
|
NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases secretion increases expression |
ISO EXP |
Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of IL6 protein] Eugenol results in increased secretion of IL6 protein Eugenol inhibits the reaction [Thioacetamide results in increased activity of IL6 protein] Eugenol results in increased expression of IL6 mRNA |
CTD |
PMID:20036707 PMID:20043298 PMID:21870829 PMID:22245253 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Il7r |
interleukin 7 receptor |
increases expression |
ISO |
Eugenol results in increased expression of IL7R mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 2:58,452,393...58,477,757
Ensembl chr 2:58,454,217...58,477,757
|
|
G |
Inhba |
inhibin subunit beta A |
decreases expression |
ISO |
Eugenol results in decreased expression of INHBA mRNA |
CTD |
PMID:15618236 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Ipcef1 |
interaction protein for cytohesin exchange factors 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of IPCEF1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:43,237,903...43,451,735
Ensembl chr 1:43,269,202...43,427,969
|
|
G |
Itga6 |
integrin subunit alpha 6 |
increases expression |
ISO |
Eugenol results in increased expression of ITGA6 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
|
|
G |
Itgb1 |
integrin subunit beta 1 |
increases expression |
ISO |
Eugenol results in increased expression of ITGB1 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Kcna5 |
potassium voltage-gated channel subfamily A member 5 |
decreases activity |
ISO |
Eugenol results in decreased activity of KCNA5 protein |
CTD |
PMID:17720863 |
|
NCBI chr 4:159,354,689...159,358,173
Ensembl chr 4:159,350,097...159,357,697
|
|
G |
Kcnj2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
decreases expression |
ISO |
Eugenol results in decreased expression of KCNJ2 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr10:96,060,834...96,071,397
Ensembl chr10:96,060,821...96,071,445
|
|
G |
Kif23 |
kinesin family member 23 |
decreases expression |
ISO |
Eugenol results in decreased expression of KIF23 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
Eugenol results in increased expression of MAFF mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression |
ISO |
Eugenol results in increased expression of MAFG mRNA |
CTD |
PMID:20566472 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Mafk |
MAF bZIP transcription factor K |
increases expression |
ISO |
Eugenol results in increased expression of MAFK mRNA |
CTD |
PMID:20566472 |
|
NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
|
|
G |
Mcts1 |
MCTS1, re-initiation and release factor |
decreases expression |
ISO |
Eugenol results in decreased expression of MCTS1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr X:117,350,723...117,362,504
Ensembl chr X:117,350,889...117,362,504
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
ISO |
Eugenol results in increased expression of ME1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
increases expression |
ISO |
Eugenol results in increased expression of MGST1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Mir146a |
microRNA 146a |
increases expression |
ISO |
Eugenol results in increased expression of MIR146A mRNA |
CTD |
PMID:37326882 |
|
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
EXP ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP2 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP2 mRNA] Eugenol results in decreased expression of MMP2 mRNA |
CTD |
PMID:20434464 PMID:30518369 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
EXP ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of and results in increased activity of MMP9 protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of MMP9 mRNA] Eugenol results in decreased expression of MMP9 mRNA |
CTD |
PMID:20434464 PMID:30518369 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Acetic Acid results in increased activity of MPO protein]; Eugenol inhibits the reaction [Thioacetamide results in increased activity of MPO protein] |
CTD |
PMID:20036707 PMID:33245926 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mrpl35 |
mitochondrial ribosomal protein L35 |
decreases expression |
ISO |
Eugenol results in decreased expression of MRPL35 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 4:103,865,812...103,876,687
Ensembl chr 4:103,865,812...103,880,887
|
|
G |
Ms4a7 |
membrane spanning 4-domains A7 |
increases expression |
ISO |
Eugenol results in increased expression of MS4A7 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:207,969,117...207,984,743
Ensembl chr 1:207,968,761...207,983,260
|
|
G |
Mt3 |
metallothionein 3 |
increases expression |
ISO |
Eugenol results in increased expression of MT3 mRNA |
CTD |
PMID:15157811 |
|
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
increases activity |
EXP |
Eugenol results in increased activity of MTOR protein |
CTD |
PMID:36007673 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Mxd1 |
max dimerization protein 1 |
increases expression |
ISO |
Eugenol results in increased expression of MXD1 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
decreases expression |
ISO |
Eugenol results in decreased expression of MYB mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC protein] |
CTD |
PMID:20537511 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
increases expression |
ISO |
Eugenol results in increased expression of NAMPT mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
affects expression decreases expression multiple interactions |
ISO |
Eugenol affects the expression of NFE2L2 protein Eugenol results in decreased expression of NFE2L2 mRNA Eugenol promotes the reaction [NFE2L2 protein results in increased expression of NQO1 mRNA] |
CTD |
PMID:17275817 PMID:31967339 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions affects expression |
ISO EXP |
Eugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] Eugenol affects the expression of NFKB1 mRNA Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 protein] |
CTD |
PMID:10871845 PMID:19851710 PMID:20385217 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of NFKBIA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of NFKBIA protein]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKBIA protein modified form] Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKBIA protein modified form]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein] |
CTD |
PMID:12963494 PMID:19851710 PMID:20043298 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NOS2 protein]; Eugenol inhibits the reaction [Nicotine results in increased expression of NOS2 mRNA]; Eugenol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] |
CTD |
PMID:20043298 PMID:21237301 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Notch1 |
notch receptor 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of NOTCH1 protein Eugenol results in decreased expression of NOTCH1 mRNA; Eugenol results in decreased expression of NOTCH1 protein |
CTD |
PMID:31926151 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression increases activity multiple interactions |
ISO |
Eugenol results in increased expression of NQO1 mRNA; Eugenol results in increased expression of NQO1 protein Eugenol results in increased activity of NQO1 protein [Dicumarol results in decreased activity of NQO1 protein] inhibits the reaction [Eugenol results in increased expression of CD86 protein]; Eugenol promotes the reaction [NFE2L2 protein results in increased expression of NQO1 mRNA] |
CTD |
PMID:17275817 PMID:20566472 PMID:21742781 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases expression |
ISO |
Eugenol results in increased expression of NR1I2 mRNA |
CTD |
PMID:29933105 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nup88 |
nucleoporin 88 |
increases expression |
ISO |
Eugenol results in increased expression of NUP88 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr10:55,667,903...55,692,249
Ensembl chr10:55,667,906...55,692,257
|
|
G |
Or5d18 |
olfactory receptor family 5 subfamily D member 18 |
multiple interactions increases activity affects binding |
ISO |
[[Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP] which results in increased expression of EGR1 mRNA; [Eugenol binds to and results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP; [Eugenol binds to and results in increased activity of OR5D18 protein] which results in increased transport of Calcium; [Eugenol binds to OR5D18 protein] which results in increased transport of Calcium; [Eugenol results in increased activity of OR5D18 protein] which results in increased abundance of Cyclic AMP; Eugenol binds to and results in increased activity of OR5D18 protein; isomethyleugenol inhibits the reaction [[Eugenol binds to OR5D18 protein] which results in increased transport of Calcium] |
CTD |
PMID:12767924 PMID:14685265 PMID:15716417 PMID:19723634 |
|
NCBI chr 3:73,516,522...73,517,463
Ensembl chr 3:73,516,364...73,519,858 Ensembl chr 3:73,516,364...73,519,858
|
|
G |
P2rx3 |
purinergic receptor P2X 3 |
multiple interactions |
EXP |
Eugenol inhibits the reaction [P2RX3 protein affects the activity of Adenosine Triphosphate] |
CTD |
PMID:19967073 |
|
NCBI chr 3:70,080,850...70,124,664
Ensembl chr 3:70,080,851...70,125,178
|
|
G |
Paics |
phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase |
decreases expression |
ISO |
Eugenol results in decreased expression of PAICS mRNA |
CTD |
PMID:17374397 |
|
NCBI chr14:31,199,086...31,232,731
Ensembl chr14:31,173,541...31,232,635
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
Eugenol affects the reaction [Methylnitronitrosoguanidine affects the cleavage of PARP1 protein] |
CTD |
PMID:20434464 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
ISO EXP |
Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PCNA protein] |
CTD |
PMID:19851710 PMID:20043298 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pde4b |
phosphodiesterase 4B |
increases expression |
ISO |
Eugenol results in increased expression of PDE4B mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 5:116,799,819...117,369,155
Ensembl chr 5:116,799,971...117,367,696
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
increases expression |
ISO |
Eugenol results in increased expression of PGD mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Picalm |
phosphatidylinositol binding clathrin assembly protein |
increases expression |
ISO |
Eugenol results in increased expression of PICALM mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:144,056,415...144,138,045
Ensembl chr 1:144,056,721...144,137,557
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
increases expression |
EXP ISO |
Eugenol results in increased expression of PIK3R1 mRNA |
CTD |
PMID:20724125 PMID:21870829 |
|
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
|
|
G |
Plat |
plasminogen activator, tissue type |
increases expression |
ISO |
Eugenol results in increased expression of PLAT mRNA |
CTD |
PMID:17374397 |
|
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
increases expression |
ISO |
Eugenol results in increased expression of PMAIP1 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of POU5F1 protein Eugenol results in decreased expression of POU5F1 mRNA; Eugenol results in decreased expression of POU5F1 protein |
CTD |
PMID:31926151 |
|
NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions increases expression |
ISO |
Eugenol analog binds to and results in increased activity of PPARG protein Eugenol results in increased expression of PPARG mRNA 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eugenol analog binds to and results in increased activity of PPARG protein]; Eugenol analog binds to and results in increased activity of PPARG protein |
CTD |
PMID:20064974 PMID:21870829 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppbp |
pro-platelet basic protein |
multiple interactions increases expression |
ISO |
Eugenol results in increased expression of and results in increased secretion of PPBP protein Eugenol results in increased expression of PPBP mRNA |
CTD |
PMID:23624239 |
|
NCBI chr14:17,302,326...17,303,130
Ensembl chr14:17,302,326...17,303,130
|
|
G |
Prdx3 |
peroxiredoxin 3 |
decreases expression |
ISO |
Eugenol results in decreased expression of PRDX3 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:260,001,642...260,014,064
Ensembl chr 1:260,001,637...260,014,111
|
|
G |
Ptger3 |
prostaglandin E receptor 3 |
decreases expression |
ISO |
Eugenol results in decreased expression of PTGER3 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 2:246,606,131...246,750,970
Ensembl chr 2:246,606,183...246,684,434
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
increases expression |
ISO |
Eugenol results in increased expression of PTGR1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression decreases expression |
ISO EXP |
Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 mRNA]; Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] Eugenol results in increased expression of PTGS2 mRNA Eugenol results in decreased expression of PTGS2 mRNA Eugenol inhibits the reaction [Thioacetamide results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [Thioacetamide results in increased expression of PTGS2] Eugenol inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased abundance of Dinoprostone]; Eugenol inhibits the reaction [[Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein] which results in increased metabolism of Arachidonic Acid]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased activity of PTGS2 protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; Eugenol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] |
CTD |
PMID:12757841 PMID:16101137 PMID:17509409 PMID:20036707 PMID:20043298 PMID:21807015 PMID:21939359 PMID:30806763 More...
|
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of RB1 protein |
CTD |
PMID:22686307 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Reck |
reversion-inducing-cysteine-rich protein with kazal motifs |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of RECK protein] |
CTD |
PMID:20434464 |
|
NCBI chr 5:58,102,961...58,169,516
Ensembl chr 5:58,102,981...58,169,502
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO EXP |
Eugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RELA protein] Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA protein] |
CTD |
PMID:10871845 PMID:19851710 PMID:20043298 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rgs1 |
regulator of G-protein signaling 1 |
increases expression |
ISO |
Eugenol results in increased expression of RGS1 mRNA |
CTD |
PMID:17374397 PMID:20713136 |
|
NCBI chr13:56,018,546...56,022,889
Ensembl chr13:56,018,554...56,022,984
|
|
G |
Rpl27a |
ribosomal protein L27A |
increases expression |
ISO |
Eugenol results in increased expression of RPL27A mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 1:163,539,732...163,542,771
|
|
G |
Rrm2b |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
increases expression |
ISO |
Eugenol results in increased expression of RRM2B mRNA |
CTD |
PMID:21704725 |
|
NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
|
|
G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
increases expression |
ISO |
Eugenol results in increased expression of SAT1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
|
|
G |
Sdc2 |
syndecan 2 |
increases expression |
ISO |
Eugenol results in increased expression of SDC2 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 7:64,127,185...64,239,885
Ensembl chr 7:64,127,110...64,241,081
|
|
G |
Septin11 |
septin 11 |
decreases expression |
ISO |
Eugenol results in decreased expression of SEPTIN11 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr14:14,844,759...14,990,856
Ensembl chr14:14,844,580...14,990,853
|
|
G |
Serpinb3 |
serpin family B member 3 |
increases expression |
ISO |
Eugenol results in increased expression of SERPINB3 mRNA |
CTD |
PMID:30806763 |
|
NCBI chr13:23,274,120...23,280,660
Ensembl chr13:23,274,484...23,313,682
|
|
G |
Slamf1 |
signaling lymphocytic activation molecule family member 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of SLAMF1 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr13:84,270,316...84,305,497
Ensembl chr13:84,270,316...84,305,497
|
|
G |
Slc16a10 |
solute carrier family 16 member 10 |
increases expression |
ISO |
Eugenol results in increased expression of SLC16A10 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr20:43,454,819...43,567,839
Ensembl chr20:43,459,709...43,567,839
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
increases expression |
ISO |
Eugenol results in increased expression of SLC2A3 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
increases expression |
ISO EXP |
Eugenol results in increased expression of SLC2A4 mRNA |
CTD |
PMID:20724125 PMID:21870829 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
increases expression |
ISO |
Eugenol results in increased expression of SLC7A11 mRNA |
CTD |
PMID:26198647 PMID:30806763 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression decreases expression multiple interactions |
ISO |
Eugenol results in increased expression of SOD1 mRNA Eugenol results in decreased expression of SOD1 mRNA; Eugenol results in decreased expression of SOD1 protein Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD1 mRNA]; Glutathione promotes the reaction [Eugenol results in decreased expression of SOD1 mRNA] |
CTD |
PMID:16101137 PMID:20566472 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression decreases expression multiple interactions |
ISO |
Eugenol results in increased expression of SOD2 mRNA Eugenol results in decreased expression of SOD2 mRNA; Eugenol results in decreased expression of SOD2 protein Acetylcysteine promotes the reaction [Eugenol results in decreased expression of SOD2 mRNA]; Glutathione promotes the reaction [Eugenol results in decreased expression of SOD2 mRNA] |
CTD |
PMID:16101137 PMID:20566472 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sod3 |
superoxide dismutase 3 |
increases expression |
ISO |
Eugenol results in increased expression of SOD3 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
Eugenol results in increased expression of SQSTM1 mRNA |
CTD |
PMID:26198647 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
Eugenol results in increased expression of SRXN1 mRNA |
CTD |
PMID:20566472 PMID:26198647 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
decreases expression |
ISO |
Eugenol results in decreased expression of STAT1 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
increases expression |
ISO |
Eugenol results in increased expression of STAT4 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stat5b |
signal transducer and activator of transcription 5B |
increases expression |
ISO |
Eugenol results in increased expression of STAT5B mRNA |
CTD |
PMID:17374397 |
|
NCBI chr10:85,704,841...85,775,856
Ensembl chr10:85,705,670...85,775,668
|
|
G |
Sult1c3 |
sulfotransferase family 1C member 3 |
increases sulfation |
ISO |
SULT1C1 protein results in increased sulfation of Eugenol |
CTD |
PMID:9560327 |
|
NCBI chr 9:7,221,580...7,266,991
Ensembl chr 9:7,221,578...7,267,030
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
multiple interactions |
EXP |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TIMP2 mRNA]; Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TIMP2 protein] |
CTD |
PMID:20434464 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tlr4 |
toll-like receptor 4 |
increases expression |
ISO |
Eugenol results in increased expression of TLR4 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression affects expression |
ISO EXP |
Eugenol inhibits the reaction [[Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Eugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] Eugenol results in increased expression of TNF mRNA Eugenol affects the expression of TNF mRNA Eugenol inhibits the reaction [Chlorpyrifos results in increased expression of TNF protein]; Eugenol inhibits the reaction [Thioacetamide results in increased activity of TNF protein] [Methoxychlor co-treated with Eugenol] results in increased expression of TNF protein; [Parathion co-treated with Eugenol] results in increased expression of TNF protein; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Bacterial Toxins results in increased secretion of TNF protein]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Eugenol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; Eugenol inhibits the reaction [Nicotine results in increased expression of TNF mRNA]; Eugenol inhibits the reaction [Nicotine results in increased secretion of TNF protein] |
CTD |
PMID:10871845 PMID:12963494 PMID:17509409 PMID:20036707 PMID:20043298 PMID:20385217 PMID:20639367 PMID:20920556 PMID:21237301 PMID:21807015 PMID:21870829 PMID:30806763 PMID:32096903 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
increases expression |
ISO |
Eugenol results in increased expression of TNFAIP3 mRNA |
CTD |
PMID:20713136 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
increases expression |
ISO |
Eugenol results in increased expression of TNFAIP6 mRNA |
CTD |
PMID:17374397 PMID:20713136 |
|
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases mutagenesis increases expression |
EXP ISO |
Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of TP53 protein] Eugenol results in increased mutagenesis of TP53 gene Eugenol results in increased expression of TRP53 mRNA; Eugenol results in increased expression of TRP53 protein Eugenol promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TRP53 protein] |
CTD |
PMID:15576237 PMID:19851710 PMID:20043298 PMID:20537511 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp63 |
tumor protein p63 |
decreases expression |
ISO |
Eugenol results in decreased expression of TP63 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
multiple interactions increases activity |
EXP |
[2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide binds to and results in decreased activity of TRPA1 protein] which results in decreased susceptibility to Eugenol Eugenol results in increased activity of TRPA1 protein |
CTD |
PMID:22426238 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
multiple interactions increases activity |
ISO EXP |
Eugenol binds to and results in increased activity of TRPV3 protein [Eugenol binds to and results in increased activity of TRPV3 protein] which results in increased transport of Calcium; Eugenol binds to and results in increased activity of TRPV3 protein [Eugenol results in increased activity of TRPV3 protein] which results in increased transport of Calcium |
CTD |
PMID:16617338 PMID:20086034 PMID:21593771 |
|
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
|
|
G |
Txn2 |
thioredoxin 2 |
increases expression |
ISO |
Eugenol results in increased expression of TXN2 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
Eugenol results in increased expression of TXNRD1 mRNA |
CTD |
PMID:20566472 PMID:23445166 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
increases expression |
ISO |
Eugenol results in increased expression of TXNRD2 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
|
|
G |
Ugdh |
UDP-glucose 6-dehydrogenase |
increases expression |
ISO |
Eugenol results in increased expression of UGDH mRNA |
CTD |
PMID:16292757 |
|
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
ISO |
UGT1A1 protein results in increased glucuronidation of Eugenol |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
increases expression |
ISO |
Eugenol results in increased expression of UGT1A6 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of Eugenol |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b1 |
UDP glucuronosyltransferase 2 family, polypeptide B1 |
increases metabolic processing |
ISO |
UGT2B17 protein results in increased metabolism of Eugenol |
CTD |
PMID:8798464 |
|
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
|
|
G |
Ugt2b15 |
UDP glucuronosyltransferase family 2 member B15 |
increases metabolic processing |
EXP |
UGT2B15 protein results in increased metabolism of Eugenol |
CTD |
PMID:7574722 |
|
NCBI chr14:20,768,015...20,783,599
Ensembl chr14:20,768,015...20,783,589
|
|
G |
Vdr |
vitamin D receptor |
increases expression |
ISO |
Eugenol results in increased expression of VDR mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
G |
Zbtb17 |
zinc finger and BTB domain containing 17 |
decreases expression |
ISO |
Eugenol results in decreased expression of ZBTB17 mRNA |
CTD |
PMID:17374397 |
|
NCBI chr 5:153,753,508...153,774,613
Ensembl chr 5:153,753,569...153,774,609
|
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
EXP |
N-acetyl-N-formyl-5-methoxykynurenamine inhibits the reaction [Streptozocin results in increased phosphorylation of MAPT protein] |
CTD |
PMID:31833155 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
ISO |
gingerol inhibits the reaction [ABCB1 protein results in increased transport of Digoxin] |
CTD |
PMID:18385293 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
ISO |
gingerol inhibits the reaction [TNF protein results in decreased expression of ADIPOQ mRNA]; gingerol inhibits the reaction [TNF protein results in decreased expression of and results in decreased secretion of ADIPOQ protein] |
CTD |
PMID:18577375 PMID:21851089 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
gingerol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:27451028 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
gingerol results in increased expression of APAF1 mRNA; gingerol results in increased expression of APAF1 protein |
CTD |
PMID:19481070 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apoe |
apolipoprotein E |
multiple interactions |
ISO |
gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of BAX protein]; gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of BCL2 protein]; gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of CASP3 protein]; gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of RELA protein]; gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of TRP53 protein] |
CTD |
PMID:37121058 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
ISO |
gingerol inhibits the reaction [TNF protein results in increased phosphorylation of ATF2 protein] |
CTD |
PMID:18577375 |
|
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [gingerol results in increased expression of BAX protein]; gingerol inhibits the reaction [Testosterone results in decreased expression of BAX protein] gingerol inhibits the reaction [hypoxia-reoxygenation increases expression of Bax protein in neural crest-derived cells] gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of BAX protein]; gingerol inhibits the reaction [Testosterone results in decreased expression of BAX protein]; gingerol inhibits the reaction [TNF protein results in increased expression of BAX protein] gingerol results in increased expression of BAX mRNA; gingerol results in increased expression of BAX protein |
CTD RGD |
PMID:18030663 PMID:19481070 PMID:25034532 PMID:28249781 PMID:37121058 PMID:34962339 More...
|
RGD:155882488 |
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO |
gingerol results in decreased expression of BCL2 mRNA; gingerol results in decreased expression of BCL2 protein gingerol inhibits the reaction [hypoxia-reoxygenation decreases expression of Bcl2 protein in neural crest-derived cells] gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of BCL2 protein]; gingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein]; gingerol inhibits the reaction [TNF protein results in decreased expression of BCL2 protein] [gingerol co-treated with Hydrogen Peroxide] results in increased expression of BCL2 protein; Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BCL2 protein]; gingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein] |
CTD RGD |
PMID:18030663 PMID:19481070 PMID:25034532 PMID:27451028 PMID:28249781 PMID:37121058 PMID:34962339 More...
|
RGD:155882488 |
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
gingerol inhibits the reaction [hypoxia-reoxygenation decreases expression of Bdnf protein in neural crest-derived cells] |
RGD |
PMID:34962339 |
RGD:155882488 |
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Becn1 |
beclin 1 |
multiple interactions |
ISO |
[gingerol co-treated with Hydrogen Peroxide] results in increased expression of BECN1 protein |
CTD |
PMID:27451028 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BID protein] |
CTD |
PMID:25034532 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BIRC5 protein]; gingerol inhibits the reaction [Testosterone results in increased expression of BIRC5 protein] |
CTD |
PMID:18030663 PMID:25034532 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Casp3 |
caspase 3 |
increases expression increases cleavage multiple interactions affects activity |
ISO EXP |
gingerol results in increased expression of CASP3 mRNA; gingerol results in increased expression of CASP3 protein gingerol results in increased cleavage of CASP3 protein gingerol inhibits the reaction [Chlorpyrifos results in increased activity of CASP3 protein] gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of CASP3 protein]; gingerol inhibits the reaction [Dextran Sulfate results in increased activity of CASP3 protein]; gingerol inhibits the reaction [Testosterone results in decreased expression of CASP3 protein]; gingerol inhibits the reaction [TNF protein results in increased expression of CASP3 protein] gingerol affects the activity of CASP3 protein [TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP3 protein; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP3 protein]; gingerol inhibits the reaction [Testosterone results in decreased expression of CASP3 protein] |
CTD |
PMID:17454143 PMID:18030663 PMID:19481070 PMID:25034532 PMID:28249781 PMID:28373059 PMID:28421826 PMID:37121058 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases cleavage affects activity |
ISO |
[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein] gingerol results in increased cleavage of CASP8 protein gingerol affects the activity of CASP8 protein |
CTD |
PMID:17454143 PMID:25034532 PMID:28249781 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases expression increases cleavage multiple interactions affects activity |
ISO |
gingerol results in increased expression of CASP9 mRNA; gingerol results in increased expression of CASP9 protein gingerol results in increased cleavage of CASP9 protein gingerol inhibits the reaction [Testosterone results in decreased expression of CASP9 protein] gingerol affects the activity of CASP9 protein |
CTD |
PMID:17454143 PMID:18030663 PMID:19481070 PMID:28249781 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
ISO EXP |
gingerol inhibits the reaction [Benzo(a)pyrene results in decreased activity of CAT protein]; gingerol inhibits the reaction [Dextran Sulfate results in decreased activity of CAT protein]; gingerol inhibits the reaction [sodium arsenite results in decreased activity of CAT protein] gingerol inhibits the reaction [Chlorpyrifos results in decreased activity of CAT protein] |
CTD |
PMID:22285432 PMID:28373059 PMID:28421826 PMID:31004597 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
gingerol results in decreased expression of CCNB1 mRNA; gingerol results in decreased expression of CCNB1 protein |
CTD |
PMID:28249781 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression decreases expression |
ISO |
[gingerol co-treated with Cycloheximide] results in increased degradation of CCND1 protein gingerol results in increased expression of CCND1 mRNA; gingerol results in increased expression of CCND1 protein gingerol results in decreased expression of CCND1 mRNA; gingerol results in decreased expression of CCND1 protein |
CTD |
PMID:18058799 PMID:26498061 PMID:28249781 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
ISO |
gingerol results in decreased expression of CCNE1 mRNA; gingerol results in decreased expression of CCNE1 protein |
CTD |
PMID:28249781 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
gingerol results in decreased expression of CDK1 mRNA |
CTD |
PMID:28249781 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
gingerol results in decreased expression of CDK4 protein |
CTD |
PMID:18058799 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression |
ISO |
gingerol results in decreased expression of CDKN1A mRNA |
CTD |
PMID:28249781 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
decreases expression |
ISO |
gingerol results in decreased expression of CDKN1B mRNA |
CTD |
PMID:28249781 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
decreases expression multiple interactions |
ISO |
gingerol results in decreased expression of CEBPA mRNA; gingerol results in decreased expression of CEBPA protein GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA mRNA]; GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA protein] |
CTD |
PMID:26498061 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [gingerol results in decreased expression of CFLAR protein] |
CTD |
PMID:25034532 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions |
ISO |
gingerol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of CHEK2 protein] |
CTD |
PMID:28988496 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Ctnnb1 |
catenin beta 1 |
affects localization increases expression multiple interactions |
ISO |
gingerol affects the localization of CTNNB1 protein gingerol results in increased expression of CTNNB1 mRNA gingerol results in increased expression of and affects the localization of CTNNB1 protein gingerol promotes the reaction [IL1B protein results in increased expression of CTNNB1 protein] |
CTD |
PMID:18058799 PMID:26498061 PMID:27645308 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
increases response to substance |
ISO |
CYP2C19 mRNA results in increased susceptibility to gingerol |
CTD |
PMID:29555536 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
gingerol inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Midazolam] |
CTD |
PMID:18385293 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
increases expression |
ISO |
gingerol results in increased expression of DUSP10 mRNA |
CTD |
PMID:17151092 |
|
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
|
|
G |
Dvl2 |
dishevelled segment polarity protein 2 |
increases expression |
ISO |
gingerol results in increased expression of DVL2 mRNA |
CTD |
PMID:26498061 |
|
NCBI chr10:54,723,356...54,732,823
Ensembl chr10:54,723,411...54,732,820
|
|
G |
Fas |
Fas cell surface death receptor |
affects activity |
ISO |
gingerol affects the activity of FAS protein |
CTD |
PMID:17454143 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fasn |
fatty acid synthase |
decreases expression |
ISO |
gingerol results in decreased expression of FASN mRNA; gingerol results in decreased expression of FASN protein |
CTD |
PMID:26498061 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
gingerol inhibits the reaction [Glucose results in increased secretion of FN1 protein] |
CTD |
PMID:21829520 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
ISO |
gingerol inhibits the reaction [Dextran Sulfate results in decreased expression of FSHB protein] |
CTD |
PMID:28421826 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression multiple interactions |
ISO |
gingerol results in increased expression of GDF15 mRNA; gingerol results in increased expression of GDF15 protein GSK3B protein affects the reaction [gingerol results in increased expression of GDF15 protein]; PRKCE protein affects the reaction [gingerol results in increased expression of GDF15 protein]; Ro 31-8220 inhibits the reaction [gingerol results in increased expression of GDF15 protein] |
CTD |
PMID:18058799 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions increases response to substance increases phosphorylation increases expression |
ISO |
gingerol inhibits the reaction [IL1B protein results in increased expression of GSK3B protein]; gingerol inhibits the reaction [IL1B protein results in increased phosphorylation of GSK3B protein]; GSK3B protein affects the reaction [gingerol results in increased expression of GDF15 protein] GSK3B protein results in increased susceptibility to gingerol GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA mRNA]; GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA protein]; GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG mRNA]; GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG protein] gingerol results in increased phosphorylation of GSK3B protein gingerol results in increased expression of GSK3B protein |
CTD |
PMID:18058799 PMID:26498061 PMID:27645308 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO |
gingerol inhibits the reaction [Oxygen deficiency results in decreased expression of HIF1A mRNA] |
CTD |
PMID:21382473 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Htr3a |
5-hydroxytryptamine receptor 3A |
decreases activity |
ISO |
gingerol results in decreased activity of HTR3A protein |
CTD |
PMID:26456648 |
|
NCBI chr 8:49,242,018...49,254,475
Ensembl chr 8:49,242,020...49,254,389
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
gingerol inhibits the reaction [IL1B protein results in increased expression of GSK3B protein]; gingerol inhibits the reaction [IL1B protein results in increased phosphorylation of GSK3B protein]; gingerol promotes the reaction [IL1B protein results in increased expression of CTNNB1 protein] gingerol inhibits the reaction [Benzo(a)pyrene results in increased expression of IL1B protein]; gingerol inhibits the reaction [Dextran Sulfate results in increased expression of IL1B protein] |
CTD |
PMID:27645308 PMID:28421826 PMID:31004597 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
gingerol inhibits the reaction [sodium arsenite results in increased expression of IL6 mRNA] |
CTD |
PMID:22285432 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
ISO |
gingerol inhibits the reaction [Dietary Fats results in increased expression of INS1 protein]; gingerol inhibits the reaction [sodium arsenite results in decreased expression of INS1 protein]; gingerol inhibits the reaction [sodium arsenite results in decreased secretion of INS1 protein] |
CTD |
PMID:21851089 PMID:22285432 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Irs1 |
insulin receptor substrate 1 |
multiple interactions |
ISO |
gingerol inhibits the reaction [sodium arsenite results in decreased expression of IRS1 mRNA]; gingerol inhibits the reaction [sodium arsenite results in decreased expression of IRS1 protein] |
CTD |
PMID:22285432 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Irs2 |
insulin receptor substrate 2 |
multiple interactions |
ISO |
gingerol inhibits the reaction [sodium arsenite results in decreased expression of IRS2 mRNA]; gingerol inhibits the reaction [sodium arsenite results in decreased expression of IRS2 protein] |
CTD |
PMID:22285432 |
|
NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
gingerol inhibits the reaction [TNF protein results in increased phosphorylation of JUN protein] |
CTD |
PMID:18577375 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Klkb1 |
kallikrein B1 |
multiple interactions decreases expression |
ISO |
gingerol inhibits the reaction [Testosterone results in increased expression of KLKB1 protein] gingerol results in decreased expression of KLKB1 protein |
CTD |
PMID:18030663 |
|
NCBI chr16:46,958,634...46,982,054
Ensembl chr16:46,958,707...46,982,053
|
|
G |
Lats1 |
large tumor suppressor kinase 1 |
increases expression |
ISO |
gingerol results in increased expression of LATS1 protein |
CTD |
PMID:32926756 |
|
NCBI chr 1:2,160,411...2,193,640
Ensembl chr 1:2,160,411...2,193,640
|
|
G |
Ldhc |
lactate dehydrogenase C |
multiple interactions |
ISO |
gingerol inhibits the reaction [Dextran Sulfate results in increased activity of LDHC protein] |
CTD |
PMID:28421826 |
|
NCBI chr 1:97,385,984...97,403,382
Ensembl chr 1:97,382,379...97,403,378
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
gingerol inhibits the reaction [Dietary Fats results in increased expression of LEP mRNA]; gingerol inhibits the reaction [Dietary Fats results in increased expression of LEP protein] |
CTD |
PMID:21851089 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
ISO |
gingerol inhibits the reaction [Dextran Sulfate results in decreased expression of LHB protein] |
CTD |
PMID:28421826 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Lrp6 |
LDL receptor related protein 6 |
increases expression |
ISO |
gingerol results in increased expression of LRP6 mRNA |
CTD |
PMID:26498061 |
|
NCBI chr 4:167,269,856...167,400,364
Ensembl chr 4:167,270,353...167,400,497
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
[gingerol co-treated with Hydrogen Peroxide] results in increased expression of MAP1LC3B protein modified form |
CTD |
PMID:27451028 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
|
|
G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
multiple interactions |
ISO |
gingerol inhibits the reaction [TNF protein results in increased phosphorylation of MAP2K4 protein] |
CTD |
PMID:18577375 |
|
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
|
|
G |
Mir210 |
microRNA 210 |
multiple interactions |
ISO |
gingerol inhibits the reaction [hypoxia-reoxygenation increases expression of Mir210 miRNA in neural crest-derived cells] |
RGD |
PMID:34962339 |
RGD:155882488 |
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression multiple interactions decreases activity |
ISO |
gingerol results in decreased expression of MMP2 mRNA; gingerol results in decreased expression of MMP2 protein gingerol inhibits the reaction [YAP1 protein results in increased expression of MMP2 protein] gingerol results in decreased activity of MMP2 protein |
CTD |
PMID:17683926 PMID:32926756 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression decreases activity |
ISO |
gingerol results in decreased expression of MMP9 mRNA gingerol results in decreased activity of MMP9 protein |
CTD |
PMID:17683926 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP ISO |
gingerol inhibits the reaction [Chlorpyrifos results in increased activity of MPO protein] gingerol inhibits the reaction [Benzo(a)pyrene results in increased activity of MPO protein]; gingerol inhibits the reaction [Dextran Sulfate results in increased activity of MPO protein] |
CTD |
PMID:28373059 PMID:28421826 PMID:31004597 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions decreases expression |
ISO |
gingerol inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of MTOR protein] gingerol results in decreased expression of MTOR protein modified form |
CTD |
PMID:27451028 PMID:28249781 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
gingerol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]] |
CTD |
PMID:18683823 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
gingerol affects the phosphorylation of and affects the activity of NFKBIA protein |
CTD |
PMID:17454143 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
gingerol inhibits the reaction [Benzo(a)pyrene results in increased expression of NOS2 protein]; gingerol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; gingerol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; gingerol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] |
CTD |
PMID:18683823 PMID:31004597 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
[TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein] |
CTD |
PMID:25034532 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions decreases expression |
ISO |
gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG mRNA]; gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein]; GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG mRNA]; GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG protein] gingerol results in decreased expression of PPARG mRNA; gingerol results in decreased expression of PPARG protein |
CTD |
PMID:22285432 PMID:26498061 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkce |
protein kinase C, epsilon |
multiple interactions |
ISO |
PRKCE protein affects the reaction [gingerol results in increased expression of GDF15 protein] |
CTD |
PMID:18058799 |
|
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
|
|
G |
Ptges |
prostaglandin E synthase |
decreases expression increases expression |
ISO |
gingerol results in decreased expression of PTGES protein gingerol results in increased expression of PTGES mRNA |
CTD |
PMID:27645308 |
|
NCBI chr 3:14,177,892...14,189,236
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
affects expression multiple interactions |
ISO |
gingerol affects the expression of PTGS2 mRNA; gingerol affects the expression of PTGS2 protein gingerol inhibits the reaction [Benzo(a)pyrene results in increased expression of PTGS2 protein]; gingerol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] |
CTD |
PMID:17454143 PMID:18683823 PMID:31004597 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
ISO |
gingerol results in decreased phosphorylation of RB1 protein |
CTD |
PMID:18058799 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
affects expression multiple interactions affects localization |
ISO |
gingerol affects the expression of RELA protein gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of RELA protein]; gingerol inhibits the reaction [Lipopolysaccharides results in increased activity of [NFKB1 protein binds to RELA protein]]; gingerol inhibits the reaction [TNF protein results in increased expression of RELA protein] gingerol affects the localization of RELA protein |
CTD |
PMID:17454143 PMID:18683823 PMID:37121058 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
decreases expression |
ISO |
gingerol results in decreased expression of RPS6KB1 protein modified form |
CTD |
PMID:28249781 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
ISO |
gingerol inhibits the reaction [sodium arsenite results in decreased expression of SLC2A4 mRNA]; gingerol inhibits the reaction [sodium arsenite results in decreased expression of SLC2A4 protein] |
CTD |
PMID:22285432 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
multiple interactions |
ISO |
gingerol inhibits the reaction [Glucose results in increased expression of SNAI1 mRNA] |
CTD |
PMID:21829520 |
|
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
|
|
G |
Snai2 |
snail family transcriptional repressor 2 |
decreases expression multiple interactions |
ISO |
gingerol results in decreased expression of SNAI2 protein gingerol inhibits the reaction [YAP1 protein results in increased expression of SNAI2 protein] |
CTD |
PMID:32926756 |
|
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
gingerol inhibits the reaction [Oxygen deficiency results in decreased activity of SOD1 protein]; gingerol inhibits the reaction [Oxygen deficiency results in decreased expression of SOD1 mRNA] |
CTD |
PMID:21382473 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
gingerol inhibits the reaction [Oxygen deficiency results in decreased activity of SOD2 protein]; gingerol inhibits the reaction [Oxygen deficiency results in decreased expression of SOD2 mRNA] |
CTD |
PMID:21382473 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
gingerol inhibits the reaction [Benzo(a)pyrene results in increased expression of TNF protein]; gingerol inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; gingerol inhibits the reaction [sodium arsenite results in increased expression of TNF mRNA]; gingerol inhibits the reaction [sodium arsenite results in increased expression of TNF protein]; gingerol inhibits the reaction [TNF protein results in decreased expression of ADIPOQ mRNA]; gingerol inhibits the reaction [TNF protein results in decreased expression of and results in decreased secretion of ADIPOQ protein]; gingerol inhibits the reaction [TNF protein results in decreased expression of BCL2 protein]; gingerol inhibits the reaction [TNF protein results in increased expression of BAX protein]; gingerol inhibits the reaction [TNF protein results in increased expression of CASP3 protein]; gingerol inhibits the reaction [TNF protein results in increased expression of RELA protein]; gingerol inhibits the reaction [TNF protein results in increased expression of TRP53 protein]; gingerol inhibits the reaction [TNF protein results in increased phosphorylation of ATF2 protein]; gingerol inhibits the reaction [TNF protein results in increased phosphorylation of JUN protein]; gingerol inhibits the reaction [TNF protein results in increased phosphorylation of MAP2K4 protein] gingerol inhibits the reaction [Chlorpyrifos results in increased expression of TNF protein] |
CTD |
PMID:18577375 PMID:21851089 PMID:22285432 PMID:28373059 PMID:28421826 PMID:31004597 PMID:37121058 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions increases response to substance |
ISO |
[gingerol results in increased expression of TP53 protein] which results in increased susceptibility to TNFSF10 protein; [TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP3 protein; [TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein; [TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of CASP8 protein]; Acetylcysteine inhibits the reaction [[TNFSF10 protein co-treated with gingerol] results in increased cleavage of PARP1 protein]; TP53 protein affects the reaction [gingerol results in increased susceptibility to TNFSF10 protein] |
CTD |
PMID:25034532 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tp53 |
tumor protein p53 |
increases expression multiple interactions |
ISO |
gingerol results in increased expression of TP53 protein gingerol inhibits the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of TRP53 protein]; gingerol inhibits the reaction [Testosterone results in decreased expression of TRP53 protein]; gingerol inhibits the reaction [TNF protein results in increased expression of TRP53 protein] [gingerol results in increased expression of TP53 protein] which results in increased susceptibility to TNFSF10 protein; [Testosterone co-treated with gingerol] results in increased expression of TP53 protein; gingerol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TP53 protein]; TP53 protein affects the reaction [gingerol results in increased expression of TNFRSF10B protein]; TP53 protein affects the reaction [gingerol results in increased susceptibility to TNFSF10 protein] |
CTD |
PMID:18030663 PMID:25034532 PMID:28988496 PMID:37121058 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vim |
vimentin |
decreases expression multiple interactions |
ISO |
gingerol results in decreased expression of VIM protein gingerol inhibits the reaction [YAP1 protein results in increased expression of VIM protein] |
CTD |
PMID:32926756 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
decreases expression |
ISO |
gingerol results in decreased expression of XIAP protein |
CTD |
PMID:25034532 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
G |
Yap1 |
Yes1 associated transcriptional regulator |
affects localization multiple interactions |
ISO |
gingerol affects the localization of YAP1 protein [gingerol co-treated with YAP1 protein] results in increased phosphorylation of YAP1 protein; gingerol inhibits the reaction [YAP1 protein results in increased expression of MMP2 protein]; gingerol inhibits the reaction [YAP1 protein results in increased expression of SNAI2 protein]; gingerol inhibits the reaction [YAP1 protein results in increased expression of VIM protein]; gingerol results in decreased expression of and results in increased phosphorylation of YAP1 protein |
CTD |
PMID:32926756 |
|
NCBI chr 8:5,095,705...5,166,808
Ensembl chr 8:5,095,722...5,167,010
|
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Guaiacol binds to ALB protein |
CTD |
PMID:11334365 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Car1 |
carbonic anhydrase 1 |
decreases activity |
ISO |
Guaiacol results in decreased activity of CA1 protein |
CTD |
PMID:19231207 |
|
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
|
|
G |
Car2 |
carbonic anhydrase 2 |
decreases activity |
ISO |
Guaiacol results in decreased activity of CA2 protein |
CTD |
PMID:19231207 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Comt |
catechol-O-methyltransferase |
multiple interactions |
ISO |
COMT mutant form inhibits the reaction [catechol results in increased abundance of Guaiacol] |
CTD |
PMID:24141029 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Guaiacol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] |
CTD |
PMID:17465205 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Sult1c3 |
sulfotransferase family 1C member 3 |
increases sulfation |
ISO |
SULT1C1 protein results in increased sulfation of Guaiacol |
CTD |
PMID:9560327 |
|
NCBI chr 9:7,221,580...7,266,991
Ensembl chr 9:7,221,578...7,267,030
|
|
|
G |
Aqp9 |
aquaporin 9 |
multiple interactions |
ISO |
AQP9 gene mutant form inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased abundance of Homovanillic Acid] |
CTD |
PMID:29566083 |
|
NCBI chr 8:71,797,231...71,837,485
Ensembl chr 8:71,797,234...71,837,395
|
|
G |
Comt |
catechol-O-methyltransferase |
multiple interactions |
ISO EXP |
[tolcapone results in decreased activity of COMT protein] which results in decreased abundance of Homovanillic Acid |
CTD |
PMID:11793163 PMID:15190105 PMID:16012872 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Maob |
monoamine oxidase B |
multiple interactions |
EXP |
[Selegiline results in decreased activity of MAOB protein] which results in decreased abundance of Homovanillic Acid |
CTD |
PMID:16012872 |
|
NCBI chr X:5,907,327...6,010,996
Ensembl chr X:5,907,266...6,011,003
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions |
ISO |
NOS1 protein affects the reaction [Methamphetamine results in decreased abundance of Homovanillic Acid] |
CTD |
PMID:11085313 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
increases abundance |
ISO |
NR3C1 protein results in increased abundance of Homovanillic Acid |
CTD |
PMID:11226678 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
multiple interactions |
EXP |
[beta-funaltrexamine binds to and results in decreased activity of OPRM1 protein] inhibits the reaction [Morphine results in increased abundance of Homovanillic Acid] |
CTD |
PMID:8884884 |
|
NCBI chr 1:43,160,057...43,413,409
Ensembl chr 1:43,160,057...43,413,409
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
[PARP1 protein results in increased susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] which results in increased abundance of Homovanillic Acid |
CTD |
PMID:10318960 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Sct |
secretin |
increases abundance |
ISO |
SCT protein results in increased abundance of Homovanillic Acid |
CTD |
PMID:16168596 |
|
NCBI chr 1:196,382,857...196,383,668
Ensembl chr 1:196,382,856...196,383,658
|
|
G |
Slc22a8 |
solute carrier family 22 member 8 |
multiple interactions |
EXP |
Homovanillic Acid inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate] |
CTD |
PMID:10224140 |
|
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
|
|
G |
Tfam |
transcription factor A, mitochondrial |
decreases abundance |
ISO |
TFAM gene mutant form results in decreased abundance of Homovanillic Acid |
CTD |
PMID:28595911 |
|
NCBI chr20:17,356,243...17,368,293
Ensembl chr20:17,356,197...17,368,292
|
|
G |
Vdr |
vitamin D receptor |
multiple interactions increases abundance |
ISO |
Calcitriol promotes the reaction [VDR protein results in increased abundance of Homovanillic Acid] |
CTD |
PMID:27450565 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases activity affects localization multiple interactions |
ISO |
isoeugenol results in increased activity of AHR protein isoeugenol affects the localization of AHR protein 3'-methoxy-4'-nitroflavone inhibits the reaction [isoeugenol results in increased activity of AHR protein] |
CTD |
PMID:16972787 PMID:22686307 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahrr |
aryl-hydrocarbon receptor repressor |
increases expression |
ISO |
isoeugenol results in increased expression of AHRR mRNA |
CTD |
PMID:22686307 |
|
NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases expression |
ISO |
isoeugenol results in increased expression of AKR1B1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
isoeugenol results in increased expression of AKR1B10 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
increases expression |
ISO |
isoeugenol results in increased expression of AKR1C1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression increases activity |
ISO |
isoeugenol results in increased expression of AKR1C2 mRNA isoeugenol results in increased activity of AKR1C2 promoter |
CTD |
PMID:20491607 PMID:21195160 |
|
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
increases expression |
ISO |
isoeugenol results in increased expression of AKR1C3 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Ar |
androgen receptor |
affects binding |
EXP |
isoeugenol binds to AR protein |
CTD |
PMID:14565775 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression |
ISO |
isoeugenol results in increased expression of ATF3 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Cat |
catalase |
increases expression |
ISO |
isoeugenol results in increased expression of CAT mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
decreases secretion |
ISO |
isoeugenol results in decreased secretion of CCL2 protein |
CTD |
PMID:20488241 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl27 |
C-C motif chemokine ligand 27 |
increases expression |
ISO |
isoeugenol results in increased expression of CCL27 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 5:56,941,402...56,948,511
Ensembl chr 5:56,941,402...56,948,506
|
|
G |
Cd274 |
CD274 molecule |
increases expression |
ISO |
isoeugenol results in increased expression of CD274 protein |
CTD |
PMID:20488241 |
|
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
decreases expression |
ISO |
isoeugenol results in decreased expression of CDK6 protein |
CTD |
PMID:22686307 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
isoeugenol results in increased expression of CDKN1B protein |
CTD |
PMID:22686307 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
increases expression |
ISO |
isoeugenol results in increased expression of CXCL2 protein |
CTD |
PMID:23178550 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
isoeugenol results in increased expression of CYP1A1 mRNA |
CTD |
PMID:20491607 PMID:22686307 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
increases expression |
ISO |
isoeugenol results in increased expression of DNAJB4 mRNA |
CTD |
PMID:23999411 PMID:27965148 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Fech |
ferrochelatase |
increases expression |
ISO |
isoeugenol results in increased expression of FECH mRNA |
CTD |
PMID:20566472 |
|
NCBI chr18:57,945,123...57,978,327
Ensembl chr18:57,945,122...57,979,348
|
|
G |
Ftl1 |
ferritin light chain 1 |
increases expression |
ISO |
isoeugenol results in increased expression of FTL mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases expression |
ISO |
isoeugenol results in increased expression of G6PD mRNA |
CTD |
PMID:20566472 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression |
ISO |
isoeugenol results in increased expression of GCLC mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
isoeugenol results in increased expression of GCLM mRNA |
CTD |
PMID:20566472 PMID:23999411 PMID:27965148 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
isoeugenol results in increased expression of GPX3 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases expression |
ISO |
isoeugenol results in increased expression of GSR mRNA |
CTD |
PMID:20566472 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
isoeugenol results in increased expression of HMOX1 mRNA |
CTD |
PMID:20491607 PMID:20566472 PMID:23445166 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
increases expression |
ISO |
isoeugenol results in increased expression of HSPA6 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr13:83,273,176...83,274,317
|
|
G |
Hsph1 |
heat shock protein family H (Hsp110) member 1 |
increases expression |
ISO |
isoeugenol results in increased expression of HSPH1 mRNA |
CTD |
PMID:23999411 |
|
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
|
|
G |
Ifng |
interferon gamma |
increases secretion |
ISO |
isoeugenol results in increased secretion of IFNG protein |
CTD |
PMID:22245253 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il18 |
interleukin 18 |
increases expression |
ISO |
isoeugenol results in increased expression of IL18 protein |
CTD |
PMID:23063874 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
isoeugenol results in increased expression of IL1A protein |
CTD |
PMID:23178550 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il2 |
interleukin 2 |
multiple interactions increases secretion |
ISO |
isoeugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA]; isoeugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased secretion of IL2 protein] isoeugenol results in increased secretion of IL2 protein |
CTD |
PMID:17630204 PMID:22245253 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il6 |
interleukin 6 |
increases secretion |
ISO |
isoeugenol results in increased secretion of IL6 protein |
CTD |
PMID:22245253 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Maff |
MAF bZIP transcription factor F |
increases expression |
ISO |
isoeugenol results in increased expression of MAFF mRNA |
CTD |
PMID:20491607 PMID:20566472 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mafg |
MAF bZIP transcription factor G |
increases expression |
ISO |
isoeugenol results in increased expression of MAFG mRNA |
CTD |
PMID:20566472 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Mafk |
MAF bZIP transcription factor K |
increases expression |
ISO |
isoeugenol results in increased expression of MAFK mRNA |
CTD |
PMID:20566472 |
|
NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
isoeugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; MAPK1 protein affects the reaction [isoeugenol affects the expression of NOS2] |
CTD |
PMID:17698059 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
isoeugenol inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]; MAPK3 protein affects the reaction [isoeugenol affects the expression of NOS2] |
CTD |
PMID:17698059 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
ISO |
isoeugenol results in increased expression of ME1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
increases expression |
ISO |
isoeugenol results in increased expression of MGST1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
isoeugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] |
CTD |
PMID:10871845 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
isoeugenol inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; NFKBIA protein affects the reaction [isoeugenol affects the expression of NOS2] |
CTD |
PMID:17698059 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
isoeugenol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; isoeugenol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; MAPK1 protein affects the reaction [isoeugenol affects the expression of NOS2]; MAPK3 protein affects the reaction [isoeugenol affects the expression of NOS2]; NFKBIA protein affects the reaction [isoeugenol affects the expression of NOS2] |
CTD |
PMID:17698059 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression |
ISO |
isoeugenol results in increased expression of NQO1 mRNA |
CTD |
PMID:20491607 PMID:20566472 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Or5d18 |
olfactory receptor family 5 subfamily D member 18 |
multiple interactions |
ISO |
isoeugenol binds to and results in decreased activity of OR5D18 protein; isoeugenol binds to and results in increased activity of OR5D18 protein |
CTD |
PMID:15574817 PMID:21142015 |
|
NCBI chr 3:73,516,522...73,517,463
Ensembl chr 3:73,516,364...73,519,858 Ensembl chr 3:73,516,364...73,519,858
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
increases expression |
ISO |
isoeugenol results in increased expression of PGD mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Ptgr1 |
prostaglandin reductase 1 |
increases expression |
ISO |
isoeugenol results in increased expression of PTGR1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases expression |
ISO |
isoeugenol results in decreased expression of RB1 protein |
CTD |
PMID:22686307 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
isoeugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] isoeugenol inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein] |
CTD |
PMID:10871845 PMID:17698059 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
increases expression multiple interactions |
ISO |
isoeugenol results in increased expression of SOCS3 mRNA; isoeugenol results in increased expression of SOCS3 protein KT 5720 inhibits the reaction [isoeugenol results in increased expression of SOCS3 mRNA] |
CTD |
PMID:21969073 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression |
ISO |
isoeugenol results in increased expression of SOD1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
increases expression |
ISO |
isoeugenol results in increased expression of SOD2 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sod3 |
superoxide dismutase 3 |
increases expression |
ISO |
isoeugenol results in increased expression of SOD3 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Srxn1 |
sulfiredoxin 1 |
increases expression |
ISO |
isoeugenol results in increased expression of SRXN1 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Tlr2 |
toll-like receptor 2 |
increases expression |
ISO |
isoeugenol results in increased expression of TLR2 mRNA |
CTD |
PMID:17936526 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases secretion |
ISO |
isoeugenol inhibits the reaction [TNF protein results in increased activity of [NFKB1 protein binds to RELA protein]] isoeugenol results in increased secretion of TNF protein |
CTD |
PMID:10871845 PMID:22245253 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trim16 |
tripartite motif-containing 16 |
multiple interactions increases expression |
ISO |
[Indomethacin co-treated with isoeugenol] results in increased expression of TRIM16 mRNA isoeugenol results in increased expression of TRIM16 mRNA |
CTD |
PMID:21284934 |
|
NCBI chr10:47,485,982...47,509,010
Ensembl chr10:47,486,297...47,551,907
|
|
G |
Txn2 |
thioredoxin 2 |
increases expression |
ISO |
isoeugenol results in increased expression of TXN2 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 7:109,496,772...109,510,378
Ensembl chr 7:109,496,761...109,510,359
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
isoeugenol results in increased expression of TXNRD1 mRNA |
CTD |
PMID:20566472 PMID:23445166 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
increases expression |
ISO |
isoeugenol results in increased expression of TXNRD2 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
increases expression |
ISO |
isoeugenol results in increased expression of UGT1A6 mRNA |
CTD |
PMID:20566472 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Zfp36 |
zinc finger protein 36 |
increases expression multiple interactions |
ISO |
isoeugenol results in increased expression of ZFP36 protein KT 5720 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein]; SB 203580 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein] |
CTD |
PMID:21969073 |
|
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
|
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
EXP |
isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Hydrogen Peroxide]; isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Malondialdehyde]; isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Reactive Oxygen Species]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:15607907 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
isorhapontigenin results in decreased expression of CCND1 protein |
CTD |
PMID:37619952 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] results in increased expression of CDH1 protein |
CTD |
PMID:37619952 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] inhibits the reaction [CTNNB1 protein modified form binds to NEDD9 protein]; [sodium bichromate co-treated with isorhapontigenin] results in decreased localization of CTNNB1 protein; [sodium bichromate co-treated with isorhapontigenin] results in decreased phosphorylation of CTNNB1 protein |
CTD |
PMID:37619952 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT1 protein |
CTD |
PMID:37619952 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3A protein |
CTD |
PMID:37619952 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3B protein |
CTD |
PMID:37619952 |
|
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
affects expression |
EXP |
isorhapontigenin affects the expression of FOS protein |
CTD |
PMID:15607907 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] results in increased phosphorylation of GSK3B protein |
CTD |
PMID:37619952 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
affects activity |
EXP |
isorhapontigenin affects the activity of IKBKB protein |
CTD |
PMID:15607907 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
affects expression |
EXP |
isorhapontigenin affects the expression of JUN protein |
CTD |
PMID:15607907 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
EXP |
isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:15607907 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
EXP |
isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:15607907 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:15607907 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Meg3 |
maternally expressed 3 |
multiple interactions |
ISO |
isorhapontigenin inhibits the reaction [sodium bichromate results in decreased expression of MEG3] |
CTD |
PMID:37619952 |
|
NCBI chr 6:128,491,808...128,524,010
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression |
ISO |
isorhapontigenin results in decreased expression of MKI67 protein |
CTD |
PMID:37619952 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated 9 |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] inhibits the reaction [CTNNB1 protein modified form binds to NEDD9 protein]; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of and results in decreased localization of NEDD9 protein; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of NEDD9 mRNA |
CTD |
PMID:37619952 |
|
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP |
isorhapontigenin affects the degradation of and affects the phosphorylation of NFKBIA protein |
CTD |
PMID:15607907 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Snai2 |
snail family transcriptional repressor 2 |
multiple interactions |
ISO |
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of SNAI2 protein |
CTD |
PMID:37619952 |
|
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
|
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
multiple interactions decreases expression |
ISO |
isosilybin inhibits the reaction [T0901317 results in increased expression of ACACA mRNA] isosilybin results in decreased expression of ACACA mRNA |
CTD |
PMID:36347319 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
increases expression |
ISO |
isosilybin results in increased expression of ACOX1 mRNA |
CTD |
PMID:36347319 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Cd36 |
CD36 molecule |
multiple interactions |
ISO |
isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CD36 mRNA] |
CTD |
PMID:36347319 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
multiple interactions |
ISO |
isosilybin promotes the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CPT1A mRNA] |
CTD |
PMID:36347319 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Fas |
Fas cell surface death receptor |
decreases expression multiple interactions |
ISO |
isosilybin results in decreased expression of FAS mRNA isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of FAS protein] |
CTD |
PMID:36347319 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
multiple interactions |
ISO |
isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of MTTP mRNA]; isosilybin inhibits the reaction [T0901317 results in decreased expression of MTTP mRNA] |
CTD |
PMID:36347319 |
|
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
decreases expression multiple interactions |
ISO |
isosilybin results in decreased expression of PNPLA3 mRNA isosilybin inhibits the reaction [T0901317 results in increased expression of PNPLA3 mRNA] |
CTD |
PMID:36347319 |
|
NCBI chr 7:115,293,538...115,314,077
Ensembl chr 7:115,293,538...115,314,077
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA mRNA]; isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARA protein] |
CTD |
PMID:36347319 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
decreases expression multiple interactions |
ISO |
isosilybin results in decreased expression of SREBF1 mRNA isosilybin inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of SREBF1 protein]; isosilybin inhibits the reaction [T0901317 results in increased expression of SREBF1 mRNA]; isosilybin inhibits the reaction [T0901317 results in increased expression of SREBF1 protein] |
CTD |
PMID:36347319 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
ISO |
KN 93 inhibits the reaction [Digoxin results in increased expression of ABCB1 protein]; KN 93 inhibits the reaction [Ouabain results in increased expression of ABCB1 protein] |
CTD |
PMID:19647009 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Aco1 |
aconitase 1 |
multiple interactions |
EXP |
KN 93 inhibits the reaction [Cadmium Chloride affects the localization of ACO1 protein] |
CTD |
PMID:25106854 |
|
NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
multiple interactions |
ISO |
KN 93 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein] |
CTD |
PMID:32522522 |
|
NCBI chr 8:20 | |